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Abstract 
 
 
Deep brain stimulation (DBS) is the dominant surgical therapy for medically-
refractory Parkinson’s Disease (PD) and Essential Tremor (ET). Despite its 
widespread use and success in treating the physical symptoms of many movement 
disorders, the mechanism of DBS is not understood, and optimal targeting 
protocols are yet to be determined. The success of the surgery is highly dependent 
upon proper placement of the electrode in the brain. However, the anatomical 
targets for PD and ET DBS—the subthalamic nucleus (STN) and ventral 
intermediate (Vim) nucleus of the thalamus, respectively—are not visible on 
conventional magnetic resonance imaging. Neurosurgeons typically locate these 
structures using atlas-based indirect targeting methods. Due to the imprecision of 
these techniques, multiple passes are required during surgery to find the 
appropriate structure(s), increasing the risk of intracranial hemorrhage. The 
purpose of this work was to optimize targeting in DBS for PD and ET.  
 
In our first study, we evaluated the most common indirect STN targeting methods 
with our validated 3-Tesla MRI protocol optimized for STN visualization. We 
calculated the indirect targets as prescribed by midcommissural point-based (MCP) 
and red nucleus-based (RN) methods, and compared those coordinates to the 
position of the STN. We found that RN-based targeting is statistically superior to 
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MCP-based targeting and should be routinely used in the absence of direct STN 
visualization.  
 
In our next study, we investigated the volume of tissue activated (VTA) in 
thalamic Vim DBS. First, we developed a k-means clustering algorithm that 
operates on diffusion tensor imaging data to semi-automatically segment the 
thalamus into its functionally-distinct nuclei. We segmented individual patient 
thalami and an atlas thalamus in an existing VTA model, and created an 
individualized VTA model by utilizing each patient’s own anatomy and tissue 
conductivity. We measured stimulation overlaps with relevant nuclei for clinically 
efficacious stimulation settings. There was a statistical trend towards greater 
precision in individualized modeling’s electrode placement with respect to the Vim 
nucleus, and our preliminary results indicated that individualized VTA modeling 
may better explain tremor control than existing atlas-based VTA modeling.  
 
Finally, utilizing the methods from our prior study, we investigated the ability of 
atlas-based and individualized VTA modeling methods to explain common side 
effects (sustained sensory paresthesias and dysarthria) from thalamic DBS. We 
found that only individualized VTA modeling can predict dysarthria, thus 
justifying its use over atlas-based modeling.  
 
The results of this work advance the understanding of proper DBS targeting for 
movement disorders, and our VTA modeling system represents the most 
individualized approach for ET DBS surgical planning. Optimized DBS targeting 
improves surgical safety and overall surgical outcome.  
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  Chapter 1
 
Introduction 
 
 
Deep brain stimulation (DBS) is a highly effective surgical therapy for the 
reduction of the physical symptoms of medically-refractory Parkinson’s Disease 
(PD), Essential Tremor (ET), and other movement disorders [1]. DBS evolved out 
of a need for a reversible alternative to ablative brain surgery. Despite the 
effectiveness of DBS, the mechanism of action is not understood; it is theorized 
that DBS activates the regions of the brain that it stimulates via direct axonal 
stimulation [2, 3], overriding any erroneous, disease-producing neural behavior [2, 
4] to suppress tremor and other symptoms. The clinical efficacy of DBS surgery is 
highly dependent on proper placement of the DBS electrode, as small differences 
in stimulation location have a dramatic impact on clinical outcome [5, 6].  
 
Neurosurgeons face challenges in proper targeting of anatomical structures 
associated with PD and ET. The anatomical targets for PD and ET DBS—the 
subthalamic nucleus (STN) and ventral intermediate (Vim) nucleus of the 
thalamus, respectively—are not visible on conventional (1.5T) magnetic resonance 
imaging (MRI) [7, 8]. Neurosurgeons typically locate these structures using a 
combination of atlas-based indirect targeting methods and intraoperative 
microelectrode recordings [9]. Due to the imprecision of these techniques, multiple 
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passes are required during surgery to find the appropriate structure(s), increasing 
the risk of intracranial hemorrhage [6, 10].  
 
 
1.1 Aims 
 
In this dissertation, we propose optimized targeting techniques for PD and ET 
DBS. For PD DBS, we investigate indirect targeting methods with a purely 
anatomical approach. For ET DBS, we employ a more complex analysis with 
volume of tissue activated (VTA) modeling and thalamic segmentation to 
investigate tremor control and side effects. 
 
In our first aim, we apply a validated 3T MRI protocol optimized for STN 
visualization to in determining the accuracy and precision of midcommissural 
point-based (MCP) and red nucleus-based (RN) indirect STN targeting methods. 
We hypothesize that RN-based targeting, though less commonly utilized, is 
actually more accurate and precise than MCP-based targeting and should be 
routinely used in the absence of direct STN visualization. 
 
Next, we present methodology for individualized VTA modeling for thalamic DBS 
for ET. We propose a k-means clustering algorithm that operates on diffusion 
tensor imaging data to semi-automatically segment the thalamus into its 
functionally-distinct nuclei, allowing for thalamic Vim targeting. Using the results 
of segmentation, we calculate individualized and atlas-based VTAs of DBS 
stimulation settings eliciting optimal tremor control. We hypothesize that 
individualized segmentations and VTA modeling result in: 1) more precise 
electrode placement with respect to the Vim nucleus and 2) VTAs that lie primarily 
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within the motor thalamus during optimal tremor control, when compared to atlas-
based VTA modeling.  
 
Lastly, utilizing the methods from the prior study, we investigate the ability of 
atlas-based and individualized VTA modeling methods to explain common side 
effects (sustained sensory paresthesias and dysarthria) from thalamic DBS. We 
hypothesize that individualized VTA modeling will better predict the incidence of 
common side effects in thalamic DBS, justifying its use over atlas-based VTA 
modeling. 
 
1.2 Background 
 
1.2.1 Movement Disorders: ET and PD 
ET is the most common movement disorder among adults and is also considered to 
be one of the most common adult neurological disorders [11-14]. Despite its 
prevalence, the etiology of ET is poorly understood [15]. ET is characterized by a 
5-10 Hz kinetic and sometimes postural tremor [16]. According to one clinical 
study, approximately 15% of ET patients were unable to work due to the severity 
of their tremor [12, 17]. Several studies have demonstrated that high-frequency 
DBS of the ventral intermediate (VIM) nucleus of the thalamus is both safe and 
effective (83% reduction) in controlling contralateral kinetic and postural tremor in 
ET [18-22]. The most common side effects from ET DBS are sensory paresthesias, 
dysarthria, and motor contractions [21, 23]. When adjusting stimulation settings, 
patients typically experience transient paresthesias or other side effects that 
dissipate quickly [23]. However, in some stimulation settings, the side effects 
become intolerable for the patient.  DBS side effects may result from improper 
 4 
 
lead placement, contact selection, or stimulation settings (voltage, frequency, pulse 
width). 
 
By contrast, PD is characterized by a 4-6 Hz resting tremor [17], and its 
mechanism is well understood. In PD, the death of dopaminergic neurons in the 
substantia nigra pars compacta (SNpc) [24] causes a dis-regulation in the basal 
ganglia that results in resting tremor, bradykinesia, and rigidity. In its healthy state, 
the SNpc operates on the striatum via the indirect (D2 receptors) and direct (D1 
receptors) pathways.  In the indirect pathway, the SNpc inhibits the striatal neurons 
that inhibit the globus pallidus externus (GPe), which in turn inhibits the STN. The 
STN then excites the globus pallidus internus (GPi), which stimulates the motor 
thalamus, providing additional stimulation to the cortex.  In the direct pathway, the 
SNpc excites striatal neurons that inhibit the GPi, which in turn inhibits the motor 
thalamus and thus the stimulation to the cortex, modulating the effect of the 
indirect pathway.  In PD, lack of activity from the SNpc causes excessive activity 
in the STN and a lack of activity in the GPi, ultimately resulting in excessive 
inhibition of the thalamus and a lack of stimulation of the cortex [25, 26].  
 
1.2.2 DBS Targeting for ET and PD 
Due to the inability to visualize thalamic nuclei with MRI [8], the Vim nucleus is 
commonly targeted using an indirect approach derived from the Schaltenbrand-
Wahren atlas. The distal tip of the electrode is placed at the following coordinates 
at an anterior angle of 60-80° and a lateral angle parallel to the midsagittal plane. 
VIM distal tip indirect target, based on SW atlas [27]  
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 Vim Target (Distal Tip) 
X 11.5 mm lateral + 0.5*(3
rd
 ventricle width) 
Y Anterior to PC by 20% of AC-PC length 
Z 0 
Table 1-1. Indirect targeting of the Vim for DBS surgery. The target is derived from the 
Schaltenbrand-Wahren Atlas and represents the target coordinates for the distal tip of the DBS 
electrode. (UMich protocol)  
 
Though there are a number of reports of direct visualization of the Vim [28-30], 
none of these methods appear more reliable than indirect targeting for routine 
application.  
 
Conversely, the STN can be visualized for direct targeting with high-field MRI 
[31]; however, at institutions where such imaging is unavailable, indirect targeting 
methods derived from the Schaltenbrand-Wahren atlas are utilized. The two most 
common methods are summarized in Table 1-1. 
 
 MCP-Based Targeting RN-Based Targeting 
X 12 mm lateral 3 mm lateral of lateral border 
Y 3-4 mm posterior Y-coordinate of anterior border 
Z 3-5 mm inferior 2 mm inferior of superior border 
Table 1-2. Indirect targeting of the STN for DBS surgery. [7, 27] 
 
1.2.3 VTA Modeling 
VTA modeling allows researchers to estimate the spatial extent of activation in the 
brain during DBS by accounting for underlying tissue conductivity. The VTA is an 
estimate of the region(s) of the brain that fires action potentials under a given set of 
stimulation parameters [32].To briefly describe the VTA calculation process, a 
Fourier FEM Solver first solves the Poisson equation to determine voltage as a 
function of time and space within the patient’s brain tissue. The voltage solution is 
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dependent upon several factors, including where the electrode is placed in the 
brain, the patient’s brain conductivity at the voxel level nearest to the electrode 
contacts, the stimulation settings being modeled, and the electrode-tissue interface 
(electrode capacitance and impedance).  The VTA is defined as the region(s) for 
which the second spatial derivative of the extracellular potential distribution [33, 
34] exceeds an axonal activation threshold derived from NEURON [35] modeling 
[32, 36]. 
 
Though atlas-based VTA modeling makes several simplifying assumptions 
regarding brain structure and tissue conductivity, it provides a mechanism for 
correlating patient outcomes to the anatomical regions stimulated by DBS and for 
determining optimal stimulation settings for clinical benefit.  Frankenmolle et al. 
(2010) showed that an electric field model for DBS can predict DBS settings that 
cause fewer side effects than clinically-determined stimulation side-effects [37]. 
Chaturvedi et al. (2010) demonstrated that the electric field models for DBS can 
predict motor side-effects in PD patients [38]. There are many other published 
studies investigating STN stimulation for PD, [32, 36-42] however, ET DBS has 
yet to be modeled extensively.   
 
The accuracy of the existing VTA model is limited by its reliance on an atlas brain; 
both the anatomical nuclei and tissue conductivities are derived from the Wakana 
et al. DT-based white matter anatomy atlas [43], which may not accurately 
represent the anatomy or tissue conductivity properties of many other patients. 
There exists an opportunity to potentially improve the accuracy and precision of 
VTA modeling by moving towards an individualized approach, i.e., by utilizing 
high-field MR and DT images to construct patient anatomy and underlying tissue 
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conductivity for VTA calculation. The improved methodology may be applied to 
an investigation of thalamic DBS for ET.  
 
1.3 Overview 
 
This dissertation is organized into 5 chapters. Chapter 2 is an evaluation of the 
accuracy and precision of the most commonly utilized indirect targeting methods 
for STN DBS for PD. Chapter 3 introduces a novel targeting approach for thalamic 
DBS, and presents some preliminary evaluation of its use in VTA modeling. 
Chapter 4 presents the implementation of the methods presented in Chapter 3 to 
investigate the VTAs of side effect inducing stimulation in thalamic DBS for ET. 
Chapter 5 presents the conclusions from the work presented in this dissertation and 
proposes future directions. 
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  Chapter 2
 
Evaluating Subthalamic Nucleus Indirect Targeting with a 
Validated 3-Tesla Magnetic Resonance Imaging Protocol 
 
Abstract 
 
Background/Aims: Indirect targeting of the subthalamic nucleus (STN) is 
commonly utilized at DBS centers around the world. The superiority of either mid-
commissural point (MCP)-based or red nucleus (RN)-based indirect targeting 
remains to be established. 
 
Methods: The location of the STN was determined and statistically compared to 
MCP- and RN-based predictions in 58 STN DBS patients, using a validated 3T 
MRI protocol. The influence of additional neuroanatomical parameters on STN 
midpoint location was evaluated. Linear regression analysis was utilized to 
produce an optimized MCP/RN targeting model. Targeting coordinates at 1.5T 
were compared to results at 3T. 
 
Results: Accuracy and precision for RN-based targeting was superior to MCP-
based targeting to predict STN midpoint location for each coordinate dimension (p 
< .01 and p < .05, respectively). RN-based targeting was statistically equivalent to 
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an optimized regression-based targeting strategy incorporating multiple 
neuroanatomical parameters, including third-ventricular width and overall brain 
size. RN-based targeting at 1.5T yielded equivalent coordinates to targeting at 3T. 
 
Conclusions: RN-based targeting is statistically superior to MCP-based STN 
targeting, and accommodates broad variations in neuroanatomical parameters. 
Neurosurgeons utilizing indirect targeting of the STN may consider favoring RN-
based over MCP-based indirect targeting methods. 
 
 
Abbreviations: STN, subthalamic nucleus; SN, substantia nigra; MCP, mid-
commissural point; RN, red nucleus; PD, Parkinson disease; MRI, magnetic 
resonance imaging; RA/LA, Right/Left Anterior Border of Red Nucleus; RS/LS, 
Right/Left Superior Border of Red Nucleus; RL/LL, Right/Left Lateral Border of 
Red Nucleus. 
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2.1 Introduction 
 
Deep brain stimulation of the subthalamic nucleus (STN DBS) is an established 
surgical therapy for medically refractory Parkinson’s disease (PD) [1]. In well-
selected patients, STN DBS improves resting tremor, bradykinesia, rigidity and 
levodopa-induced dyskinesias, in a manner superior to best medical therapy [2,3].  
With the success of the therapy worldwide, thousands of patients have been treated 
with STN DBS for PD in the past 25 years [4]. 
 
While the ideal stimulation site in the STN region is not known precisely, it is 
hypothesized that the active contact of the DBS electrode should be located in the 
dorsolateral (motor) region of the STN [5-8].  Accurate targeting of the STN 
during DBS surgery is essential, as small differences in DBS electrode localization 
can dramatically influence clinical outcome [9,10].  Stimulation outside of the 
motor STN is thought to produce side effects such as cognitive decline and 
behavioral changes reported in nearly half of STN DBS cases [11-13].  However, 
targeting the STN can be very challenging. The STN is small (158 mm
3
) and 
poorly visualized on conventional (1.5T) MRI. Furthermore, it is often 
indistinguishable from the adjacent substantia nigra (SN) without the use of high 
field-strength (3T-9.4T) MRI, which is not widely available around the world [14]. 
 
To circumvent the limitations to direct STN visualization on conventional 1.5T 
MRI, neurosurgeons have utilized a combination of pre-surgical indirect targeting 
techniques and intraoperative microelectrode recordings to target the STN for DBS 
surgery [15]. These pre-surgical indirect techniques are based on the position of the 
STN relative to internal fiducial markers as imaged on MRI, such as the anterior 
and posterior commissures, according to neuroanatomical atlases [6-8,16,17]. 
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Among these indirect techniques, the most commonly used are based upon the 
location of the mid-commissural point (MCP) [18-20] or the borders of the red 
nucleus (RN) [15,17] (Table 2-1), although other targeting approaches have been 
proposed [21,22]. Optimization of pre-surgical indirect targeting methods can 
reduce the number of surgical passes, thus reducing the risk of bleeding and the 
length of surgery [10]. Further, although microelectrode recording (MER) can 
assist STN targeting with the availability of a trained electrophysiologist, the MER 
has been reported to increase the risk of bleeding [10,23]. These factors motivate 
the continued use of indirect targeting techniques during STN DBS surgery. 
 
 MCP-Based Targeting RN-Based Targeting 
X 12 mm lateral 3 mm lateral of lateral border 
Y 3-4 mm posterior Y-coordinate of anterior border 
Z 3-5 mm inferior 2 mm inferior of superior border 
Table 2-1. Indirect targeting of the STN for DBS surgery  
 
Determining the relative quality of indirect STN targeting techniques is of broad 
interest to neurosurgeons, particularly at international centers or in intraoperative 
MR settings where the absence of high field strength MR imaging ( > 1.5T) make 
direct STN targeting difficult.  Two measures of targeting quality are of interest: 
accuracy and precision. Accuracy is the measure of the degree of closeness 
between the prediction of a quantity and its actual value.  For example the 
prediction of the STN midpoint will be close to its actual location in an accurate 
targeting technique. Precision, by contrast, is the measure of the degree of 
variability in repeated applications of the targeting technique. For example, if the 
distance from the predicted STN location to its actual location is highly variable 
across patients, the targeting technique has low precision. 
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Previous studies have evaluated targeting techniques by comparing their 
predictions to the coordinates of the most efficacious, active DBS electrode contact 
[17].  While the ideal stimulation site in the STN region is not known precisely, it 
is hypothesized that the active contact of the DBS electrode should be located in 
the dorsolateral (motor) region of the STN [5-8].  The challenge of these studies is 
that the location of the DBS electrode, and therefore the location of the most 
efficacious contact, is itself constrained by and dependent upon the targeting 
method used during surgery.  With the development of a validated 3T MRI 
protocol to visualize the STN [1], the opportunity arises to evaluate targeting 
methods without this limitation.  Determining which targeting method most 
reliably predicts the location of the midpoint of the STN may allow neurosurgeons 
to target the dorsolateral region of the STN more reliably and efficiently.  
  
In this study, we locate the midpoint of the MR-visualized STN (Figure 2-1). We 
then compare the accuracy and precision of MCP- and RN-based targeting 
methods relative to this location. Since we are able to visualize the midpoint of the 
STN directly, we then evaluate the impact of neuroanatomical variability, such as 
changes in third-ventricle size, on STN location. We utilize regression analysis to 
optimize the indirect targeting model and to compare this optimization with 
traditional MCP- and RN-based targeting of the STN. Finally, we evaluate RN-
based targeting utilizing images at 1.5T field strength compared to RN-based 
targeting utilizing images at 3T field strength. Taken together, our findings suggest 
that neurosurgeons employing RN-based indirect targeting may expect more 
consistent results than others employing MCP-based indirect targeting. 
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2.2 Methods 
 
2.2.1 Patient Selection 
We evaluated the 3T MR images of 58 patients who had undergone bilateral STN 
DBS for advanced idiopathic PD (42 men, 16 women, age mean ± SD 63 ± 7 
years, range 46-78 years).  Selection criteria for DBS included a diagnosis of 
idiopathic PD, with the presence of motor fluctuations not optimally managed with 
medications, or severe levodopa-unresponsive tremor.  Patients with 
contraindications to 3T MRI scanning, structural abnormalities on preoperative 
MRI, or dementia by neuropsychological testing were excluded from the study.  
We performed the study in accordance with the policies of the Medical 
Institutional Review Board of the University of Michigan.  
 
2.2.2 MR Imaging and Analysis 
Patients under evaluation for DBS surgery received pre-operative volumetric 3T 
MRI (Philips Achieva, Philips, Amsterdam, Netherlands) scans. The 3T MRI 
protocol was developed by our group, optimized for STN visualization, and has 
been validated against cadaveric anatomical studies and intraoperative 
electrophysiology [1]. The images were oriented in Talairach coordinate space 
along the intercommissural and midsagittal planes (Analyze 9.0, AnalyzeDirect 
Inc.,Overland Park, KS). Consistent with neurosurgical convention, the mid-
commissural point (MCP) was designated as the origin. Positive X, Y, and Z 
directions were defined as left, anterior, and inferior, consistent with targeting 
using the Leksell Stereotactic Frame (Elekta AB, Stockholm, Sweden). 
Windowing of the 3T MR data for visualization was uniformly centered at the 
level that maximized contrast between STN and substantia nigra (SNR) and a 
width twice that amount, to minimize image measurement variability.  
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Figure 2-1. Coordinate determination of the STN midpoint.  A graphical representation of the 
right STN is shown against coronal and sagittal planes. Anterior and posterior poles are defined 
in the coronal plane at the MR-visualized STN border. The STN midpoint is defined as 
equidistant between anterior and posterior poles.  
 
Since the shape of the STN is not precisely ellipsoidal, we defined the midpoint of 
the STN as the location midway between the oral and caudal poles of the STN, 
which were selected on coronal MRI for closest correspondence to a well-
established atlas of the human brain (Atlas of the Human Brain, plates 31-38) [24] 
(Figure 2-1).  Our method is consistent with previously published methodology on 
determining the midpoint of the STN [9]. Coordinates of the RN borders were 
measured as defined in prior studies [15,17]. Briefly, the anterior, lateral, and 
superior borders were selected as the most anterior (axial plane), lateral (axial 
plane), and superior (coronal plane) points on volumetric 3T MRI in Talairach 
orientation. 
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In addition to STN midpoint location, whole-brain neuroanatomical parameters 
were measured as follows (35 men, 14 women, age mean ± SD 63 ± 7 years, range 
46-78 years; 9 patients in the original group were excluded due to incomplete 
whole-brain imaging data): Brain length was measured as maximal antero-
posterior dimension in the intercommissural plane on either side of the midline. 
Brain width was measured as the distance between insular cortical pia at the 
anterior commissure and temporoparietal cortical pia at the posterior commissure. 
Frontal horn width was measured as the maximal lateral ventricular width on axial 
slices. Third ventricular width was measured in the intercommissural plane at the 
mid-commissural point. Brain height was measured as the maximal vertical length 
in coronal images at the anterior commissure. All anatomical measurements were 
performed by the neurosurgeon performing the DBS surgeries (PGP) to minimize 
inter-observer variability. 
 
To allow comparison between imaging field strengths, RN-based indirect targeting 
coordinates were calculated for 10 patients who had received 3T imaging with our 
validated protocol as well as 1.5T T2-weighted imaging (TR 5550, TE 82, 2 mm 
slice thickness). Images at 1.5T were oriented in Talairach coordinate space 
through co-registration (Analyze 9.0, AnalyzeDirect Inc.,Overland Park, KS). 
Coordinates of the RN borders were measured in identical and blinded fashion to 
images acquired at 3T.  
 
2.2.3 Statistical Methods 
Statistical analysis was performed using commercially available software: SAS 
(SAS Institute Inc., Cary, NC), Excel (Microsoft Inc., Redmond, WA) and 
MATLAB (Mathworks, Natick, MA). For all comparisons, statistical significance 
is defined at the p < .05 level. Except where otherwise noted, coordinate data are 
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reported as mean ± 95% confidence interval (CI). Comparisons of coordinates 
were performed with two-tailed paired t-tests for non-independent data. The 
Bonferroni correction was utilized for multiple comparisons. Comparisons of the 
precision of standard RN-based targeting and novel targeting methods were 
performed with right-tailed F-tests. We compared the variances in each coordinate 
on each side of the brain under the null hypothesis that the variance of two normal 
populations are the same and the alternative hypothesis that the variance of the 
standard RN-targeting population is greater than the variance of the model RN-
targeting population. The best simple linear regression model for each coordinate 
was determined as the model with the highest R
2
 value that had statistically 
significant parameter estimates (p < 0.05).  For each linear regression model, the 
data were tested for homoscedasticity with the Kolmogorov-Smirnov test. Sources 
of statistical variability in our data include quantization effects due to voxel 
representation intrinsic to MR imaging and human error in measurement [1]. 
 
2.3 Results 
 
2.3.1 STN Midpoint Coordinates 
Table 2-2 reports the X-, Y-, and Z-coordinate locations of the right and left STN 
in our study (mean ± 95% CI, n = 58). The STN midpoints are symmetrical within 
95% CI limits for individual patients. The MCP is designated as the origin and left, 
anterior, and superior represent increasing X, Y, and Z coordinates, respectively. 
With this convention, the right STN midpoint was located at X = -10.90 ± 0.31 
mm, Y = -0.66 ± 0.35 mm, Z = -3.63 ± 0.29 mm. The left STN midpoint was 
located at X = 11.41 ± 0.28, Y = -1.23 ± 0.34, Z = -3.88 ± 0.31. These values 
compare well with traditional targeting coordinates for the dorsolateral STN (Table 
2-1).  
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 X (mm) Y (mm) Z (mm) 
R STN -10.90 ± 0.31 -0.66 ± 0.35 -3.63 ± 0.29 
L STN 11.41 ± 0.28 -1.23 ± 0.34 -3.88 ± 0.31 
Table 2-2. Coordinates of the STN midpoint determined by validated 3T MRI. Measurements are 
reported as mean ± 95% CI (N = 58). 
 
Table 2-3. Pearson’s correlation coefficients for STN coordinates and neuroanatomical 
parameters.  Empty cells indicate the absence of statistically significant correlation (N=49).  
2.3.2 Correlation of STN Midpoint Coordinates and Neuroanatomical Parameters 
Table 2-3 reports the correlation between right and left STN midpoint coordinates 
and major neuroanatomical parameters, as defined in our Methods. Significant 
correlation for the laterality (X-coordinate) of the STN is present for CSF spaces in 
the brain. Correlation between laterality and maximal frontal horn width is weaker, 
though statistically significant (Right: r = -0.33, p = 0.02; Left: r = 0.37, p < 0.01). 
By comparison, we find stronger correlation between STN laterality and third 
ventricle width (Right: r = -0.54, p < 0.01; Left: r = 0.51, p < 0.01). Linear 
regression of bilateral STN midpoint separation and third ventricular width yields 
strong correlation (Figure 2-2), with third-ventricular width accounting for 40% of 
the variance in STN separation (R
2
 = 0.4). Juxtaposed with this strong overall 
explanatory value, the individual lateral coordinates of the right and left STNs are 
only weakly explained by the width of the third ventricle (Right: R
2
 = 0.29; Left: 
R
2
 = 0.26). In the rostrocaudal dimension, there are no statistically significant 
correlations observed between the Y-coordinate of the STN midpoint and any of 
the neuroanatomical parameters that we examined. In the dorsoventral dimension, 
Coordinate 
R Brain 
Length 
L Brain 
Length 
Brain Width 
at AC 
Brain Width 
at PC 
Frontal Horn 
Width 
Third Ventricle 
Width at MCP 
Brain 
Height 
R STN X     
-0.33 
p = 0.02 
-0.54 
p < 0.01 
 
R STN Y        
R STN Z 
-0.42 
p < 0.01 
-0.40 
p = 0.04 
     
L STN X     
0.37 
p < 0.01 
0.51 
p < 0.01 
 
L STN Y        
L STN Z 
-0.35 
p = 0.01 
-0.34 
p = 0.02 
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there are significant correlations bilaterally between brain length (maximal antero-
posterior dimension in the intercommissural plane) and the Z-coordinate of the 
STN midpoint (Right: r = -0.40 to -0.42, p = 0.01; Left: r = -0.34 to -0.35, p = 
0.01). Empty cells in the table indicate the absence of statistically significant 
correlations. 
 
 
Figure 2-2. Linear regression of STN midpoint separation and third ventricular width.  With 
greater third ventricular width, the lateral distance between bilateral STN midpoints increases. 
 
2.3.3 Comparison of MCP- and RN-based Targeting Accuracy and Precision 
Figure 2-3 compares the results of MCP- and RN-based targeting accuracy and 
precision for the coordinates of the STN midpoint. Absolute errors in targeting are 
plotted for each of the coordinates and targeting methods, using optimized offsets 
for our dataset. Average absolute errors in targeting are lower for RN-based 
targeting (mean ± SD, Right and Left pooled; X, Y, Z: 0.67 ± 0.45 mm, 0.77 ± 0.54 
mm, 0.56 ± 0.40 mm) than for MCP-based targeting (mean ± SD, Right and Left 
pooled; X, Y, Z: 0.91 ± 0.70 mm, 1.04 ± 0.81 mm, 0.92 ± 0.71 mm) for each 
coordinate (p < .01 in all cases), indicating that indirect RN-based targeting is 
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more accurate than MCP-based targeting. Standard deviations in the absolute 
errors, as indicated by the error bars in the figure, are a measure of targeting 
precision. For all coordinates, RN-based targeting is also significantly more precise 
than MCP-based targeting (F-test, p < 0.05 for each coordinate direction). 
 
 
Figure 2-3. Comparison of MCP- and RN-based targeting accuracy.  Absolute errors in targeting 
(mean ± SD) are plotted for MCP, RN, and Optimized RN models. Greyscale indicates X, Y, and 
Z coordinates. 
 
 
2.3.4 Creating an Optimized Targeting Model 
To create an optimized targeting model, we evaluated the targeting parameters 
(location relative to MCP, RN borders, neuroanatomical parameters) with 
regression analysis. Table 2-4 reports the final optimized model parameters. 
Regression analysis eliminated the MCP coordinates and all other measured 
neuroanatomical parameters as statistically insignificant. By contrast, the borders 
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of the RN correlate strongly with STN midpoint coordinates, with slopes for all 
regression models approximately equal to one (range 0.91 to 1.05). The best-
optimized predictors for the Y-coordinate of the right STN and all of the left STN 
coordinates are the same used during standard RN-based targeting (lateral, 
anterior, and superior RN borders for X, Y, and Z STN midpoint coordinates, 
respectively).   For the right STN midpoint, however, the X-coordinate is better 
predicted by the superior border of the RN than the lateral border (R
2
 = .56 vs. R
2 
= 
.48), while the Z-coordinate is better predicted by the anterior border of the RN 
than the superior border (R
2
 = .70 vs. R
2
 = .65). These small improvements in 
predictive power result in a small but statistically significant improvement in 
accuracy for the optimized regression model, without improvement in precision 
(Fig. 2-3). 
 
Regression Line R² 
RSTNx = 1.05 × RSx – 5.77 .56 
RSTNy = 0.94 × RAy + 1.42 .45 
RSTNz = 0.96 × RAz + 1.39 .70 
LSTNx = 0.91 × LLx + 3.27 .58 
LSTNy = 0.98 × LAy + 1.05 .55 
LSTNz = 1.04 × LSz – 1.75 .65 
Table 2-4. Results of STN-RN regression modeling.  (N = 58) 
 
2.3.5 Comparison of Targeting Parameters 
Table 2-5 presents the final optimized STN midpoint targeting parameters for 
MCP-based, RN-based, and regression optimized targeting methods. MCP-based 
midpoint targeting parameters are equivalent to values found in STN midpoint 
measurements. Optimized targeting parameters are determined through linear 
regression.  Both RN-based and optimized targeting strategies are significantly 
more accurate for individual patients (p < 0.05) and precise (p < 0.002) than MCP-
based targeting. RN-based and regression optimized RN-based methods are not 
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statistically distinguishable. RN-based coordinates for the STN midpoint compare 
well with traditional targeting coordinates for the dorsolateral STN (Table 2-1). 
 
 
 RSTNx RSTNy RSTNz 
MCP MCPx – 10.90 MCPy – 0.66 MCPz – 3.63 
RN RLx – 2.75 RAy + 1.55 RSz – 1.68 
Optimized RN 1.05×RSx – 5.77 0.94×RAy + 1.42 0.96×RAz + 1.39 
    
 LSTNx LSTNy LSTNz 
MCP MCPx + 11.41 MCPy – 1.23 MCPz – 3.88 
RN LLx + 2.55 LAy + 1.08 LSz – 1.84 
Optimized RN 0.91×LLx + 3.27 0.98×LAy + 1.05 1.04×LSz – 1.75 
Table 2-5. STN midpoint targeting parameters. MCP: midcommissural point; RN: red nucleus; 
STN: subthalamic nucleus; RL/LL: right and left lateral; RA/LA: right and left anterior; RS/LS: 
right and left superior; x,y,z subscripts indicate corresponding coordinate directions (N = 58). 
 
2.3.6 Evaluation of RN-Based Targeting Results at 1.5T 
Figure 2-4 illustrates 3T (Fig. 2-4A) and 1.5T (Fig 2-4B) co-registered coronal 
MRI images for the same patient. The RN is visible in both 1.5T and 3T images 
(white arrows), while the STN and SNR are only visible in 3T images. As expected 
with imaging at lower field strength, tissue contrast and delineation of structural 
borders are less distinct at 1.5T than 3T. 
 
To evaluate the application of our 3T RN-based targeting methodology to 1.5T, we 
performed a blinded comparison of RN boundary coordinates in 10 patients who 
had imaging performed at both field strengths. Maximal RN-based targeting 
coordinate differences between 3T and 1.5T images were less than one voxel, 
ranging from -0.41 ± 0.17 mm (mean ± SEM) for the right superior Z-coordinate 
(RSz) to 0.27 ± 0.22 mm for the left anterior Y-coordinate (RAy). None of the 
indirect targeting differences between images at 3T and 1.5T were statistically 
significant.  
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Figure 2-4. Comparison of coronal 3T and 1.5T MRI images for RN visualization in the same 
patient.  The RN is well visualized at both 3T (A) and 1.5T (B). By contrast the STN and SNR 
are only well visualized at 3T. 
 
2.4 Discussion 
 
Deep Brain Stimulation of the STN region is the predominant surgical therapy for 
Parkinson’s disease. Accurate surgical targeting is essential for optimal patient 
outcomes. With advances in magnetic-field strength, direct visualization of the 
STN on MR imaging has become possible in some centers. However, in the 
majority of neurosurgical centers throughout the world, where advanced 3T MRI 
imaging techniques are not available, indirect and atlas-based STN targeting 
techniques are most often utilized. A detailed evaluation of the accuracy of the two 
predominant indirect targeting techniques, MCP-based and RN-based targeting, is 
therefore of significant interest to neurosurgeons, with the potential to reduce 
surgical complexity and to shorten operative times.  
 
A B 
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We have previously reported a validated 3T MRI protocol to directly visualize the 
STN [1]. Our protocol is unique in that our MR-visualized STN has been validated 
against both published human anatomical studies and intraoperative 
electrophysiology. In this study, we utilize this validated 3T MRI protocol to 
evaluate the location of the STN midpoint, to compare MCP- and RN-based STN-
targeting techniques, and to evaluate the influence of multiple neuroanatomical 
parameters on STN location. Our study suggests that RN-based indirect targeting 
of the STN is both more accurate and more precise than MCP-based indirect 
targeting. We further determine that coordinates predicted by RN-based targeting 
at 3T match those predicted at 1.5T, indicating that neurosurgeons may wish to 
consider favoring RN-based over MCP-based indirect targeting when performing 
STN DBS surgery. 
 
2.4.1 Correlation of STN Midpoint Coordinates and Neuroanatomical Parameters 
We find significant correlation between STN location and neuroanatomical 
parameters, including CSF spaces in the brain. Strongest correlation occurs 
between third-ventricle width and STN laterality. However, explicitly 
incorporating third ventricle width into surgical planning is not required to target 
the STN: ipsilateral RN coordinates account well for STN displacements due to 
changes in the size of CSF spaces, as indicated by regression analysis. Similarly, 
RN-related variables account better for the dorsoventral location of the STN 
midpoint than brain-length neuroanatomical variables. These findings suggest that 
RN-based indirect targeting automatically compensates for multiple sources of 
anatomic variation in STN targeting. Incorporation of additional neuroanatomical 
variables into indirect RN-based STN targeting does not appear to improve 
targeting accuracy to a significant degree. By comparison, MCP-based targeting, 
with fixed lateral displacement traditionally, does not incorporate neuroanatomical 
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parameters such as third-ventricle width or shifts in STN location relative to the 
MCP.  
 
2.4.2 Comparison of MCP- and RN-based Targeting Accuracy and Precision 
Our analysis confirms and quantifies the superiority of RN-based indirect STN 
targeting over MCP-based targeting, in terms of accuracy and precision (Figure 2-
3). Absolute error, a measure of targeting accuracy, is lower for RN-based 
targeting than for MCP-based targeting in each coordinate dimension. 
Improvements in average accuracy for RN-based targeting over MCP-based 
targeting are 0.2 mm, 0.2 mm, and 0.3 mm in the X-, Y-, and Z-coordinates, 
respectively. In addition, RN-based targeting has superior precision, with reduced 
variability across patients. Based upon these findings, neurosurgeons may routinely 
consider RN-based indirect targeting over MCP-based targeting. 
 
A recent review of MR-based targeting techniques by Brunenberg et al. reported 
conflicting results regarding the superiority of RN-based targeting over MCP-
based targeting [14].  Andrade-Souza et al. reported that the RN is the more 
reliable internal fiducial marker for determining the ―optimal‖ contact in STN DBS 
[17].  The challenge of such analysis is that the location of the DBS electrode, and 
therefore the location of the most efficacious contact, is itself constrained by and 
dependent upon the targeting method chosen by the neurosurgeon. Our study 
compares indirect RN-based and MCP-based targets against the midpoint of the 
MR-visualized STN, the location of which is independent of targeting techniques. 
However, the relationship of the STN midpoint to the locus of clinically optimal 
stimulation remains to be defined precisely. Our findings indicate that the STN 
midpoint is anterior and medial to traditional indirect targeting coordinates. This is 
consistent with clinical targeting to the dorsolateral (motor) portion of the STN. To 
 29 
 
provide further clinical application of our anatomical finding, a follow-up study is 
underway to determine the optimal locus of DBS stimulation relative to the MR-
visualized STN midpoint. 
 
2.4.3 Creating an Optimized Targeting Model 
We explored the possibility of optimizing RN-based targeting through the use of 
neuroanatomical and RN-based variables with highest correlation to STN 
coordinates and regression analysis. We find that the optimized RN-based targeting 
methods are statistically indistinguishable from traditional RN-based targeting, 
despite higher correlation values. Greater statistical resolution may be achieved 
with higher sample size. However, the improvement in accuracy (< 0.1 mm) 
appears likely to be clinically insignificant. Our results therefore support the 
adoption of standard RN-based indirect targeting over more complex RN-based 
targeting techniques. 
 
2.4.4. Evaluation of RN-Based Targeting Results at 1.5T 
In this study, we utilize a validated 3T MR imaging protocol to evaluate MCP- and 
RN-based indirect targeting of the STN. Our aim is to determine and to compare 
the accuracy and precision of these commonly utilized methods of STN targeting 
for neurosurgeons lacking high-field MRI capabilities at their centers. We find that 
RN-based targeting is both more accurate and more precise than MCP-based 
targeting at 3T. An important additional step is the validation of these results at 
1.5T. RN visualization is protocol-dependent. We find that the RN (but not the 
STN) can be well visualized at 1.5T (Fig. 2-4) and that differences in targeting 
parameters calculated from 3T and 1.5T images are clinically and statistically 
insignificant. RN-based targeting at 1.5T produces the same target coordinates for 
use during STN DBS surgery as targeting at 3T. 
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2.4.5 Comparison with Previous Work on STN Localization 
Our results compare well with STN midpoint coordinates (11.8 mm lateral, 1.3 mm 
posterior, 4.0 mm inferior) in the Schaltenbrand-Wahren (S-W) atlas as well as 
previous study at 1.5T magnetic field strength, which pooled right and left STN 
coordinates to reduce statistical variability [9]. Several previous studies have 
reported the inferiority of direct targeting alone with 1.5T MRI compared to a 
combination of indirect targeting methods [17,25,26]. However, higher field 
strength appears to allow for greater localization accuracy. Several recent studies 
have reported that 3T MR imaging is a more accurate method for direct targeting 
of the STN for DBS surgery [27,28]. Our study extends these findings at 1.5T and 
3T to measure the location of the STN midpoint directly at 3T MR field strength. 
Significantly, when pooled, our measurements for the center of right and left STNs 
agree well with the earlier measurements of Daniluk et al. 
 
2.4.6 Previous Evaluation of MCP- and RN-based Targeting 
We are not the first to suggest the superiority of RN-based targeting to MCP-based 
targeting for STN targeting [15,17]. However, a statistical evaluation of targeting 
techniques at high field strength with a validated MR imaging protocol has been 
unavailable up to the present time.  Traditional MCP-based indirect targeting of the 
STN remains dominant in the neurosurgical community. In a review of 
publications on MR-based targeting techniques for STN DBS, MCP-based 
targeting was utilized far more frequently than RN-based targeting [14].  In 
addition, studies performed at 1.5T field strength have questioned the use of the 
RN as a reliable internal fiducial marker for STN location [29]. Danish et al. 
reported that 1.5T MRI is inadequate to delineate the relationship between the STN 
and RN borders.  However, at the voxel sizes in each dimension utilized in that 
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study (> 2 mm), the image resolution at the time of that study may have been 
inadequate compared to currently available technology [29]. Confounding results 
may also be MR protocol specific, as the RN may be difficult to visualize at 1.5T 
without optimization of scanning parameters.  In our 1.5T MR imaging protocol, 
the RN is well visualized, while both RN and STN are clearly visualized in our 
validated 3T imaging protocol.  Our comparison between 1.5T-based and 3T-based 
RN border measurements demonstrates that 1.5T MRI is equivalent to 3T MR in 
terms of measuring RN borders, and therefore is appropriate for indirect STN 
targeting.  Another historical criticism of RN-based targeting has been that the 
parameters for targeting were derived from the SW Atlas [17]. The atlas represents 
one representative brain specimen and thus does not capture variability among PD 
patients [9]. In the present study, validated MR imaging in a large population of 
PD patients allowed quantitative evaluation of targeting uncertainty.  
 
2.5 Conclusions 
 
RN-based indirect STN targeting is significantly more precise than MCP-based 
STN targeting, and accommodates broad changes in anatomic parameters, such as 
third ventricular width. Our analysis suggests that neurosurgeons employing RN-
based indirect targeting may expect more consistent results than others employing 
MCP-based indirect targeting at 1.5T. Future work is required to determine the 
optimal site of DBS stimulation relative to the STN midpoint and to incorporate 
this information into RN-based indirect targeting parameters during DBS surgery. 
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  Chapter 3
 
Individualized Thalamic Segmentation and Tissue 
Activation Modeling in Deep Brain Stimulation for Essential 
Tremor  
 
Abstract 
 
Background/Aims: Thalamic deep brain stimulation (DBS) is the dominant 
neurosurgical therapy for the treatment of medically refractory essential tremor 
(ET). The mechanisms of DBS-mediated tremor control remain unknown. 
However, computational modeling of DBS-induced electrical fields and volumes 
of tissue activated (VTA) have improved our understanding of the influence of 
lead location and stimulation parameters on clinical efficacy. To date, patient-
specific computational studies have relied upon atlas-based representations of 
patient anatomy for both thalamic segmentation and VTA modeling. However, 
recent advances in diffusion-tensor magnetic resonance imaging (DTI) have raised 
the possibility of an atlas-independent, patient-specific approach. In this study, we 
present a fully patient-specific methodology for DTI-based thalamic segmentation 
and VTA modeling in patients with ET and compare this approach to more 
traditional atlas-based modeling. 
 
 37 
 
Methods: Our study includes 10 patients treated with unilateral, left thalamic DBS 
for ET at our institution. For each subject, we compared the results of atlas-based 
and patient-specific thalamic segmentation and VTA modeling at clinically 
efficacious stimulation settings. Patient-specific thalamic segmentation was 
performed utilizing a novel, modified k-means clustering algorithm to delineate 
individual thalamic nuclei. Patient-specific VTA modeling was performed by 
calculating the region of neuronal activation from individual DTI-derived 
conductivity tensor fields. 
 
Results: Thalamic segmentations based on individual DTI data compared well 
with atlas-based results. All 10 of 10 patient-specific VTAs for the active contact 
at the clinically determined stimulation settings were localized to the motor 
thalamus. By comparison, only 9 of 10 atlas-based VTAs overlapped with the 
motor thalamus for the same stimulation settings. The distance of the active contact 
to the motor thalamus centroid was 4.6 ± 1.7 mm for patient-specific 
segmentations and 5.0 ± 2.9 for the atlas-based approach, although this 
improvement was not statistically significant.  
 
Conclusions: While traditional atlas-based thalamic segmentation and VTA 
modeling provides reliable means of DBS targeting and mechanistic study, 
improved precision may be possible with a patient-specific approach based on 
individual DTI imaging data. 
 
Abbreviations: DBS, deep brain stimulation; ET, Essential Tremor; VTA, 
Volume of Tissue Activated; Vim, Ventral Intermediate; Vc, Ventrocaudal; MRI, 
Magnetic Resonance Imaging; DTI, Diffusion Tensor Imaging; AC, Anterior 
Commissure; PC, Posterior Commissure; A, Anterior; VA, Ventral Anterior; VLa, 
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Ventral Lateral Anterior; VLPd, Ventral Lateral Posterior-dorsal ; VLPv, Ventral 
Lateral Posterior-ventral; VPL, Ventral Posterior Lateral; VPM, Ventral Posterior 
Medial; VM, Ventral Medial; P, Pulvinar; MD, Mediodorsal; LD,  Lateral Dorsal; 
LP, Lateral Posterior; CM, Central Median; CL, Central Lateral; LGN, Lateral 
Geniculate Nucleus; MGN,  Medial Geniculate Nucleus. 
 
  
 39 
 
3.1 Introduction 
 
Chronic, high-frequency deep brain stimulation (DBS) of the ventral lateral 
posterior-ventral (VLPv)—also known as the ventral intermediate (Vim) [1-4]—
nucleus of the thalamus is the dominant surgical therapy for controlling medically-
refractory kinetic and postural tremor in Essential Tremor (ET) [5-9]. The 
mechanisms underlying thalamic DBS are poorly understood for two reasons. 
First, despite its success in treating a variety of neurological conditions, the 
mechanism of DBS itself remains controversial [10-12].  Second, studying 
thalamic DBS has been difficult for researchers due to the challenge of establishing 
structure-function relationships in the thalamus, which has functionally distinct but 
poorly visualized nuclei [9].  
 
While direct visualization of thalamic nuclei is not possible using conventional 
MRI [9], it has been proposed that diffusion tensor imaging (DTI) can help 
delineate nuclear boundaries [13-18].  Several computational thalamic 
segmentation methods exist based on this principle [15, 17-26], and the use of DTI 
in movement disorder surgery is an emerging trend [27].  Typically, neurosurgeons 
preoperatively target the thalamus with stereotactic atlas-derived coordinates and 
refine the target during surgery with intraoperative macrostimulation and 
microelectrode recordings [9]. Improved preoperative planning could reduce the 
need for microelectrode recordings, thus minimizing the risk of intracranial 
hemorrhage [28], and improve patient outcomes overall.  
 
Computational modeling of the volume of tissue activated (VTA) in DBS has been 
used to study the stimulation locations and parameters for Parkinson’s disease (PD) 
DBS [29-36], though these methods typically rely on brain atlas warping as a 
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means of comparison across subjects.  To date, no group has analyzed the VTAs in 
ET DBS, and only three computational studies have investigated or modeled ET 
DBS [37-39] in any capacity. Therefore, we set out to combine the concepts of 
patient-specific thalamic nuclei segmentation and DBS VTA modeling. 
 
In this study, we present the first individualized VTA model for thalamic DBS in 
10 ET patients. We segmented patient thalami with a modified k-means clustering 
algorithm, and incorporated the results in a previously-published atlas-based VTA 
modeling system. We provide some preliminary comparisons of individualized and 
atlas-based modeling, leaving a detailed comparison for an accompanying study. 
This article describes our methodology, preliminary results, and discusses 
limitations and future work.  
 
3.2 Materials and Methods 
 
The overall objective of this study was to develop an individualized VTA model 
for thalamic DBS. This project integrated electrical and anatomical representations 
of the brain into a finite-element electric field modeling system for DBS [32]. 
Brain conductivity values were derived from diffusion tensor imaging (DTI). 
Thalamic anatomy was manually parcellated from pre-operative patient MRI 
scans, and then segmented into functionally distinct nuclei using a modified k-
means clustering algorithm [15]. Stimulation volumes were then calculated for the 
most clinically-efficacious stimulation settings, and their overlaps with relevant 
anatomy were compared.  
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3.2.1 Patient Selection and Clinical Data 
 
We retrospectively evaluated the VTAs of 10 ET patients who had undergone 
unilateral left Vim (VLPv) DBS for advanced idiopathic ET (6 men, 4 women, age 
mean ± SD 66 ± 7 years, range 49-74 years). Selection criteria for DBS included a 
diagnosis of idiopathic ET, with the presence of tremor no longer well-managed 
with medications. Patients with co-morbid neurological or psychiatric conditions 
were excluded. We performed the study in accordance with the policies of the 
Medical Institutional Review Board of the University of Michigan. 
 
3.2.2 Image Data Acquisition and Analysis 
 
3.2.2.1 MRI Scanning 
Patients received pre-operative volumetric 3T MRI and DTI (Philips Ingenia, 
Philips, Amsterdam, Netherlands) scans for surgical trajectory planning and post-
operative analysis. MR images were acquired using the protocol reported in [40] 
and were oriented in Talairach coordinate space along the intercommissural and 
midsagittal planes (Analyze 11.0, AnalyzeDirect Inc., Overland Park, KS).  
Consistent with neurosurgical conventions, the mid-commissural point (MCP) was 
designated as the origin.  Positive X, Y, and Z directions are defined as right, 
anterior, and inferior, consistent with finite-element modeling software 
conventions (SCIRun 4.7, Scientific Computing Institute, Salt Lake City, UT).  
 
DTI data were acquired on a 3T scanner (Philips Ingenia, Philips, Amsterdam, 
Netherlands) using a single-shot echo planar imaging sequence with a dS-SENSE 
parallel-imaging scheme (reduction factor = 2, field of view = 224 mm x 224 mm, 
1 mm x 1 mm x 2 mm voxels). Diffusion weighting was encoded along 15 
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independent orientations with a b-value of 800 s/mm². One additional image 
without diffusion weighting (b = 0 s/mm²) was also acquired.  DTI images were 
adjusted for ―jitter‖ and then resampled using cubic spline interpolation to match 
the resolution of MR image. The DTI volumes were coregistered to 3T MR 
images, and the rigid transformation matrix from the co-registration was saved. 
Analyze’s DTI module was used to calculate the eigenvalues and eigenvectors of 
the DTI volumes. 
 
3.2.2.2. CT Scanning 
Patients received post-operative CT scans 6-8 weeks after DBS surgery to confirm 
correct electrode placement using the CT protocol reported in [40]. CT images 
were oriented in Talairach space via coregistration to 3T MRI images, and the 
coordinates of the Medtronic 3387 DBS electrode contact points were recorded 
(Analyze 11.0, AnalyzeDirect Inc., Overland Park, KS).  
 
For all image coregistrations, the Normalized Mutual Information algorithm [41] in 
Analyze’s 3D Voxel Registration function was used, followed by manual 
adjustment to properly align the anterior and posterior commissures.  
 
3.2.2.3 Conductivity Tensor Calculation 
Diffusivity tensors were first calculated from DTI eigenvalues and eigenvectors in 
MATLAB (Mathworks, Natick, MA) using matrix diagonalization [42, 43]: 
 
D = QΛQ-1 = QΛQT 
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where Q is the orthogonal eigenvector matrix of diffusion tensor D and Λ is the 
diagonal eigenvalue matrix of diffusion tensor D.  Due to DTI coregistration to 
Talairach orientation, the diffusion tensors required re-orientation as follows [44]: 
 
D’ = RDRT 
 
where D’ is the re-oriented diffusion tensor, D is the original diffusion tensor, and 
R is a rotation matrix representing the rotation that occurred during coregistration.  
R was found by calculating the polar decomposition of the upper 3x3 part of the 
4x4 rigid transformation matrix from coregistration. Talairach-oriented diffusivity 
tensors were then converted to conductivity tensors as described by [45, 46].  
 
3.2.3 Thalamic Segmentation 
3D reconstructions of the thalamus and its functionally distinct nuclei were 
obtained for each patient in two steps: manual parcellation from MR images 
followed by semi-automatic segmentation with a modified k-means clustering 
algorithm [15]. Each thalamus was segmented into13 nuclei following the naming 
convention presented by the Morel histological atlas [47]: Anterior (A), Ventral 
Anterior (VA), Ventral Lateral Anterior (VLa), Ventral Lateral Posterior-dorsal 
(VLPd), Ventral Lateral Posterior-ventral (VLPv), Ventral Posterior Lateral 
(VPL), Ventral Posterior Medial (VPM), Ventral Medial (VM), Pulvinar (P), 
Mediodorsal (MD),  Lateral Dorsal (LD), Lateral Posterior (LP), Central Median 
(CM). The Central Lateral (CL), Lateral Geniculate Nucleus (LGN), and Medial 
Geniculate Nucleus (MGN) were small enough to be excluded; in most cases, the 
LGN and MGN were assumed to not be visible based on the parcellation. Of 
particular interest was the VLPv nucleus, the target nucleus for ET DBS. The 
Morel atlas was selected over the Schaltenbrand-Wahren atlas for its simplicity 
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and because it was used in two prior k-means thalamic segmentation investigations 
[15, 48].  
 
The k-means algorithm is a statistical clustering technique used in many fields. It 
allows a larger set of data to be broken up into a specified number of clusters based 
on a user-provided distance metric.  It relies on four parameters [49]: (1) the 
number of clusters to be segmented, (2) a distance metric or combination of 
metrics, (3) initial coordinates of the cluster centroids, (4) a well-defined stopping 
point for the algorithm.  The algorithm moves data into clusters in a way that 
minimizes the distance metric, iterating until the convergence criterion is reached. 
Following segmentation, we validated the algorithm by comparing pooled results 
against known anatomy from a histological atlas of the thalamus. 
 
3.2.3.1 Thalamic Parcellation 
The left thalamus was parcellated manually from high-resolution coronal MR 
images (Analyze 11.0, AnalyzeDirect Inc., Overland Park, KS).  The thalamus was 
defined in the mediolateral axis by the third ventricle and the posterior limb of the 
internal capsule and in the dorsoventral axis by the lateral ventricles and the 
subthalamic nucleus [15].  All co-registrations, anatomical measurements, and 
parcellations were performed by one investigator (LH) to minimize inter-observer 
variability.   
 
3.2.3.2 K-Means Clustering Algorithm 
The initial centroids were selected by one investigator (LH) based on a priori 
information from the Morel histological atlas [47]. We selected a distance metric 
to take into account the physical location of a voxel and the tensor at that location 
under the reasoning that voxels belonging to a nucleus would be close in physical 
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proximity and in tensor properties.  The overall dimensionless Ejk was defined as 
the normalized sum of the Mahalanobis norm and the J-Divergence [50]. 
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   is the three-dimensional coordinate vector of voxel j,  ̅  represents the 
coordinate vector of the centroid of cluster k,   is the covariance matrix of cluster 
k (recalculated at every iteration),     is the corresponding diffusion tensor of voxel 
j,  ̅  is the mean diffusion tensor for the centroid of cluster k, and a is the size of 
the tensors (a = 3).  The combination of metrics for physical proximity and tensor 
similarity follow logically from the observation that voxels within thalamic nuclei 
are near one another and have similar diffusivity (and therefore conductivity) 
tensor properties.  The algorithm calculates the distance metric between each 
cluster’s centroid and all voxels. Voxels are assigned to a cluster by minimization 
of voxel-to-cluster centroid distance, and this process repeats until the convergence 
criterion is satisfied. Like Wiegell et al. [15], we defined the stopping point of the 
algorithm as the point at which no cluster centroid shifted more than 0.1 mm from 
the previous iteration. 
 
3.2.3.3 Centroid Comparison 
Centroid coordinates of the patient segmented nuclei were pooled across subjects 
(N = 10); the Wakana DTI atlas thalamus was evaluated separately [51]. The Y-
coordinates were scaled by the AC-PC length to partially adjust for inter-subject 
variability.  Unlike previous centroid for thalamic k-means segmentation [15, 48], 
we did not register the segmentations to a normalized atlas.  As in previously 
published work [48], we compared the three-dimensional centroid coordinates of 
each segmented nucleus with atlas coordinates obtained from the Morel 
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histological atlas [47]. We also calculated the distance of the centroid coordinates 
of the segmented nuclei from the posterior commissure (PC) and compared those 
values against calculated values from the Morel histological atlas with two-tailed t-
tests at a significance level of p < 0.05.  
 
3.2.3.4 Position of DBS Leads 
The distances between VLPv centroids and the electrode contacts that best 
controlled tremor were calculated in patient and atlas space.  
 
3.2.4 Atlas-based data 
The DTI atlas is described in [51]. A single-shot echo planar imaging sequence 
was used to acquire the atlas with a b-value of 700 s/mm
2
 and a 2.2 mm isotropic 
voxel size. The left thalamus was already parcellated by hand as described in [32]. 
The atlas thalamus [51] was segmented with our k-means clustering algorithm. 
Cicerone [52] provided stereotactic electrode coordinates in atlas space. 
 
3.2.5 VTA Analysis 
The VTA is an estimate of the region(s) of the brain that fires action potentials 
under a given set of stimulation parameters [32]. We generated the VTAs for 
clinically efficacious stimulation settings and characterized their overlaps with 
relevant anatomy.  
 
All simulations were performed on a custom-built computer with 8 processors and 
48 GB memory (DEH Microsystems LLC, Cleveland, OH, USA) using BioPSE 
(Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, 
UT).  
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3.2.5.1 VTA Generation 
For each patient, individualized and atlas-based VTAs were generated. The 
individualized model followed the methodology of the atlas-based model presented 
in [29, 32, 53, 54] with the exception that all brain tissue conductivity data was 
based on patient-specific DTI data, and not derived from the Wakana et al. (2004) 
DTI atlas [51] as in all previous VTA studies.  To briefly describe the VTA 
calculation process, a Fourier FEM Solver first solves the Poisson equation to 
determine voltage as a function of time and space within the patient’s brain tissue. 
The voltage solution is dependent upon several factors, including where the 
electrode is placed in the brain, the patient’s brain conductivity at the voxel level 
nearest to the electrode contacts, the stimulation settings being modeled, and the 
electrode-tissue interface (electrode capacitance and impedance).  The VTA is 
defined as the region(s) for which the second spatial derivative of the extracellular 
potential distribution [55, 56] exceeds an axonal activation threshold derived from 
NEURON [57] modeling [29, 32]. 
 
For VTA modeling, stimulation settings were selected from each patient’s first 
stimulation programming session with a Neurologist (KLC) following the post-
operative CT scan, 6-8 weeks post-DBS surgery. We recorded the optimal DBS 
setting that controlled tremor without producing side-effects.  
 
3.2.5.2 VTA Evaluation 
For each stimulation setting, the overlap volumes between the VTA and the motor 
thalamus (VLPv, VLPd, VLa) sensory thalamus (VPM and VPL), and the internal 
capsule (IC, lateral to the thalamus) were recorded with the individualized and 
atlas-based models.  Overall agreement in VTA volumes between the two models 
was assessed with a two-tailed paired t-test.  
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3.2.6 Statistical Methods 
Statistical analysis was performed using commercially available software: Excel 
(Microsoft Inc., Redmond, WA) and MATLAB (Mathworks, Natick, MA). For all 
comparisons, statistical significance is defined at the p < .05 level, and a statistical 
trend is defined as 0.05 < p < 0.10. Sources of statistical variability in our data 
include quantization effects due to voxel representation intrinsic to MR imaging, 
motion artifacts in MR and CT imaging, and human error in measurement [40]. 
Data are displayed as mean ± SD except where otherwise noted. 
 
3.3 Results 
 
3.3.1 Clinical Outcome 
All 10 patients had improved tremor following successful DBS surgery, without 
sustained paresthesias or dysarthria.   
 
3.3.2 Thalamic Segmentation 
Representative cross-sectional images of segmented thalami are shown with 
corresponding atlas images  [47] and 3T MR images in Figure 3-1. The 
representative images demonstrate that there is good agreement in the location and 
size of the thalamic nuclei between our results and the Morel atlas, though there is 
variability in the overall size of the thalamus and locations of the thalamic nuclei 
boundaries across patients (Fig. 3-2). 
 
The repeatability of the k-means algorithm was tested on the Wakana DTI atlas 
thalamus before applying the algorithm to individual patient thalami.  We 
attempted 10 segmentations with randomized initial centroid coordinates within a 
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radius of 3 mm of the initial centroid coordinates used for the segmentation in 
VTA modeling. We calculated the average deviation of the nuclei centroids from 
the best segmentation’s centroids and pooled them across iterations (N = 10). 
 
We quantitatively compared our results to the Morel Atlas. After scaling the 
anteroposterior coordinates by the AC-PC length (patient mean ± SD AC-PC 
length = 25.8 ± 1.9 mm, Morel atlas, postmortem AC-PC length = 24 mm) to 
partially account for variation from the atlas thalamus, the average absolute 
Euclidean distance difference between the average centroids and the Morel 
centroids is 4.0 mm.  The Euclidean distance difference is 2.2 mm in the 
mediolateral axis, 2.6 mm in the anteroposterior axis, and 0.8 mm in the 
dorsoventral axis. Two-tailed t-tests reveal that the A, VA, VLa, VLPd, VLPv, 
VPL, VPM, P, and CM nuclei coordinates are not significantly different (p >> 
0.05) in absolute Euclidean distance from the PC compared to Morel atlas 
coordinates, suggesting good agreement with atlas values. Only MD, LD, LP, and 
VM nuclei centroid coordinates are significantly different (p < 0.05).  The 
algorithm produced repeatable results on a standardized atlas thalamus; on average, 
when initial centroid coordinates were randomized to a 3 mm radius, the 
segmentation yielded nuclei centroid 1.35 ± 0.84 mm from the centroids belonging 
to the best segmentation (i.e., the one used for atlas-based VTA analysis). 
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Figure 3-1. Comparison of patient segmentations with corresponding MR images and Morel 
histological atlas renderings. [47] Atlas renderings were reprinted with permission from Wiley. 
The borders of the thalamus are indicated by the dotted line (A and D). 
 
  
 
 
 
 
 
 
  
 
 
 
 
A B C 
E D F 
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Figure 3-2. Comparison of sagittal projections of segmented thalami. The k-means algorithm 
accommodates different thalamus shapes and sizes. (A) Wakana DTI atlas thalamus (B, C, D) 3 
ET patient thalami. Scale bars represent 10 mm. (key: crimson = VLa, magenta = VLPd, pink = 
VLPv, purple = VPL, brown = VPM) 
 
3.3.3 Location of DBS Active Contacts  
 
3.3.3.1 Individual Patient Analysis 
70% of the most efficacious contacts lie within the motor (VL) nucleus.  On 
average, the Final DBS active contact is 1.8 mm medial ,1.2 mm anterior, and 0.8 
mm superior to the VLPv centroid (overall distance: 4.6 ± 1.7 mm). When 
compared with a paired two-tailed t-test, there is a significant difference in location 
A B 
C D 
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between the VLPv centroids’ and the active contacts’ mediolateral coordinates (p 
< 0.05). However, there is no difference in the anteroposterior and dorsoventral 
coordinates (p > 0.05) between each patient’s VLPv centroids and the active 
contacts, indicating that the Y and Z coordinates of the optimal stimulation site are 
well-predicted with the k-means clustering algorithm’s definition of the VLPv 
centroid. Consistent with typical lead placements in ET DBS, the mean Final DBS 
Active Contact is 14.0 mm lateral, 7.5 mm anterior, and 4.6 mm superior to the PC 
[9, 39]. On average, the Distal Tip of the electrode is placed 0.5 mm medial, 1.0 
mm posterior, and 0.8 mm inferior to the VIM target defined by the S-W atlas.  
 
3.3.3.2 Atlas-Based Analysis 
60% of the most efficacious contacts lie within the motor nucleus. On average, the 
Final DBS active contact is at the medial, 0.7 mm posterior to, and 2.7 mm 
superior to the VLPv centroid (overall distance: 5.0 ± 2.9 mm). When compared 
with a paired two-tailed t-test, there is no significant difference in location between 
the VLPv centroids’ and the active contacts’ mediolateral, anteroposterior, or 
dorsoventral coordinates (p > 0.05).  
 
Our data indicates a statistical trend (F-test, p = 0.07) towards a difference in 
variance between individualized and atlas-based models (3.1 mm
2
 and 8.7 mm
2
, 
respectively). 
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3.3.4 Comparison of Individualized and Atlas-Based VTAs 
Paired t-tests show that there is no statistically significant difference between 
VTAs generated by individualized and atlas-based modeling (p = 0.18). The mean 
percentage difference between individualized and atlas-based VTAs is 6.82% ± 
13.1%. 100% of individualized VTAs of the most efficacious tremor control 
settings for each patient overlap with the motor thalamus, while only 90% of 
equivalent atlas-based VTAs overlap with the motor thalamus.  More specifically, 
90% of individualized VTAs have some overlap with the VLPv, while the 
remaining 10% overlap with the VLPd. In atlas-based modeling, 70% of VTAs 
have some overlap with the VLPv, while 20% overlap with the VLPd and 10% are 
entirely medial to the motor thalamus. There is no statistically significant 
difference in the volume of VLPv stimulation or sensory thalamus stimulation 
between models (p = 0.58 and p = 0.94, respectively).  
 
Figure 3-3 shows four examples of individualized VTAs for the most clinically-
efficacious tremor control setting. In all examples, the VTA lies primarily within 
the motor thalamus, as is expected for effective tremor control. The VLPd 
(magenta) appears to be an effective location for tremor control in addition to the 
VLPv (pink). Figure 3-4 shows two examples of patients whose individualized 
model better predicts VTA position than the atlas-based model. In both cases, 
individualized modeling predicts a VTA overlapping mostly with the motor 
thalamus, while the atlas-based model places the VTA entirely medial (Fig. 3-4A) 
or mostly posterior (Fig. 3-4C) to the motor thalamus.  
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Figure 3-3. Examples of VTAs of the most efficacious tremor control settings for four patients.  
In all examples, the VTA lies primarily within the motor thalamus.  Scale bars represent 10 mm. 
(key: crimson = VLa, magenta = VLPd, pink = VLPv, purple = VPL, brown = VPM, red = VTA)  
A B 
C D 
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Figure 3-4. Comparison of Atlas-based and Individualized VTA modeling during tremor control. 
(A) Atlas-based modeling shows a VTA during tremor control (monopolar stimulation, C+3-, 
1V) that lies mostly posteromedial to the motor thalamus. (B)  Individualized modeling of the 
same stimulation setting shows the VTA situated within the motor thalamus. (C) Atlas-based 
modeling shows a VTA during tremor control (monopolar stimulation, C+3-, 1.5V) that the VTA 
lies mostly posterior to the motor thalamus. (D) Individualized modeling of the same stimulation 
setting shows the VTA almost entirely within the motor thalamus. Scale bars represent 10 mm. 
(key: crimson = VLa, magenta = VLPd, pink = VLPv, purple = VPL, brown = VPM, red = VTA) 
 
  
A B 
C D 
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3.4 Discussion 
 
The purpose of this study is to introduce an individualized VTA model of thalamic 
DBS. We generated atlas-based and individualized VTAs for optimal tremor 
control settings in segmented thalami and compared the results. Until now, 
investigation of VTAs in thalamic DBS has been difficult due to the inability to 
visualize the functionally-distinct nuclei of the thalamus. To overcome this 
difficulty, we applied a k-means clustering algorithm on DTI data, and integrated 
the results into a finite-element electric field DBS model. Ours is the first study to 
model ET DBS VTAs and the first to model VTAs in an individualized manner 
(i.e., without the use of atlas-based anatomy or tissue conductivity).  
 
3.4.1 Previous Work 
Previous computational investigations of ET DBS relied on common brain-spaces 
or co-registering patient data to brain atlases to analyze data across patients [37-
39]. One retrospective DBS study [39] applied probabilistic diffusion tractography 
[18] within Montreal Neurological Institute (MNI) brain space to analyze the 
connectivity between the most efficacious DBS contact for tremor control and 
prefrontal, premotor, and primary motor cortical target masks. Pouratian et al. 
hypothesized that the most efficacious DBS contact for tremor control would co-
localize with the region in the thalamus with most primary motor cortex 
connectivity, but instead, the contact is typically anterior to that region in an area 
with high likelihood of connectivity with the premotor and supplementary motor 
cortices. A recent retrospective ET DBS study investigated the potential for 
improved modulation of neuronal pathways with directional DBS leads using 
finite-element electric field modeling. However, the study utilized an isotropic 
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homogeneous medium for its tissue conductivity model and warped thalamic atlas 
nuclei to patient data in place of individual segmentation [38].  
 
3.4.2 Thalamic Segmentation 
Though the functionally-distinct nuclei of the thalamus are not visible on 
conventional MRI, DTI data can help delineate thalamic nuclei [13, 14, 16]. We 
modified a k-means clustering algorithm previously published by Wiegell et al. 
(2003) [15] for semi-automatic thalamic segmentation for use in retrospectively 
evaluating clinical data. Wiegell’s k-means clustering algorithm utilized diffusivity 
tensor data to semi-automatically segment the thalamus into a pre-defined number 
of clusters.  Our algorithm differed in two ways. First, we used conductivity--not 
diffusivity--tensors for segmentation. Tuch et al. (2001) demonstrated that the 
relationship between conductivity and diffusivity is linear [45].  Therefore, there 
should be no difference in segmentation from using conductivity tensors over 
diffusivity tensors.  Secondly, though Wiegell et al. (2003) obtained good results 
by using the Frobenius norm as a tensor dissimilarity metric, we used the square 
root of the J-Divergence, or the symmetrized Kullback-Leibler divergence [50] to 
overcome some of the limitations of the Frobenius norm.  Unlike the Frobenius 
norm, the J-divergence is both affine-invariant and inherently considers the 
positive-definite quality of tensors [58].  The motion of water within brain tissue 
over time t is represented by a Gaussian distribution, and diffusion tensors are 
equivalent to the covariance matrix of the Gaussian distribution.  It is therefore 
reasonable to treat the distance between tensors as the distance between that 
Gaussian distribution [50, 58].  
 
We tested the robustness of the algorithm on a standardized atlas thalamus, and 
then applied the algorithm to patient thalami. We were able to semi-automatically 
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segment the thalamus on a patient-specific basis using conductivity tensor data 
already required for VTA modeling. The algorithm run time was less than 10 
minutes following approximately 3 hours of data pre-processing per patient. As in 
previous studies, we felt that placement of the initial centroids for the k-means 
algorithm with a priori knowledge of atlas centroid coordinates was justified [48] 
as it dramatically reduced the runtime of the algorithm and provided better 
segmentation results (comparison not shown).  Our segmentation results are 
comparable to previously-published k-means thalamic segmentation algorithms, 
despite the fact that previous studies co-registered segmentation results to the 
Morel atlas prior to comparing the nuclei centroids, naturally biasing the result [15, 
48].  Deoni et al. reported an absolute Euclidean distance difference between their 
segmented nuclei’s centroids and Morel atlas centroids of 3.3 mm, and in the 
orthogonal axes, differences of 2.2 mm (mediolateral), 1.7 mm (anteroposterior), 
and 1.3 mm (dorsoventral) [48]. Our segmentation is equivalent in the mediolateral 
axis, superior in the dorsoventral axis, but inferior in the anteroposterior axis even 
without atlas co-registration.  However, it is not entirely reasonable to treat atlas 
nuclei centroid coordinates as gold standards for comparison; variation is expected 
in nuclei location and boundaries across patients, and recent tractography studies 
reveal substantial variability across patient thalamic nuclei [17, 18]. Post-mortem 
histological staining is currently the only reliable method for assessing the 
boundaries of thalamic nuclei, though this approach would likely require a multi-
institutional longitudinal study. Pre-operatively, however, if there were a way to 
confirm the results of semi-automated thalamic segmentation, that method would 
likely be used for targeting.  
 
3.4.3 Position of DBS Leads 
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The position of the DBS leads within the segmented thalami suggests that the 
segmentation is reasonable in both an atlas thalamus and across patient thalami.  
On a patient-specific basis, the segmentation algorithm can predict the DBS active 
contact coordinates in the anteroposterior and dorsoventral axes. The inability of 
the algorithm to predict the mediolateral coordinate of the DBS active contact is 
expected, because the centroid of the VLPv is not typically the target for ET DBS 
due to the somatotopic organization of the thalamus.  As our data shows, the active 
contact is typically medial to the VLPv centroid.  This result lends credibility to the 
k-means algorithm as a potential method for surgical planning.  
 
Previous studies have argued in favor of selecting targeting methods with superior 
precision [59, 60]. When compared to Cicerone-based electrode placement, there is 
an interesting though not statistically significant difference in the variability of 
VLPv centroid to active contact distance. The lack of statistical significance is 
likely due to the relatively small sample size of our study. Coordinate-based lead 
location has been shown to not be a significant predictor of clinical outcome in 
Parkinson’s Disease [61]; VTAs may be better predictors.   
 
3.4.4 VTA Analysis 
Though there is no statistically significant difference in VTA size between models, 
there is high variability in VTA size between models due to differences in lead 
location within the thalamus. In cases with clear disagreement between electrode 
locations between models, the surrounding tissue conductivity may contribute to 
large differences in VTA size.  Atlas-based VTA modeling performs generally 
well, though our preliminary results suggest that individualized VTA modeling 
may perform better in some instances.  
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3.4.5 Limitations and Future Directions 
Because this study was retrospective, we used a thalamic segmentation method that 
utilized data from existing imaging data. There is potential for improving upon this 
thalamic segmentation method in the future with higher-resolution DTI scans or 
alternative statistical clustering approaches. Also, the small sample size of this 
study (N = 10) likely prevents finding statistical significance in some of our 
comparisons. 
 
In an accompanying study, we use this methodology to correlate side-effects of 
DBS to VTA stimulation in the thalamus for the same patients. We hope to 
validate our methodology and implement it in DBS surgical planning in a 
prospective study. 
 
3.5 Conclusions 
 
We have presented the first individualized VTA model for ET DBS patients.  
Compared to traditional stereotactic targeting of the VLPv, DTI-based thalamic 
segmentation may be a superior method for locating the centroid of the VLPv. 
Preliminary VTA modeling results indicate that clinical effects may be better 
explained with individualized modeling than by traditional atlas-based modeling. 
We explore this further in an accompanying study. 
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  Chapter 4
 
Investigation of Side Effects in Thalamic Deep Brain 
Stimulation with Individualized and Atlas-Based Volume of 
Tissue Activated Modeling 
Abstract 
 
Background/Aims: Volume of Tissue Activated (VTA) modeling has improved 
the understanding of deep brain stimulation (DBS) surgery for movement 
disorders. In a previous work, we described the development of an individualized 
VTA model for thalamic DBS for Essential Tremor (ET). Preliminary results 
indicated that individualized VTA modeling may confer some advantages over 
existing atlas-based modeling.   We sought to investigate the potential for 
individualized and atlas-based VTA modeling to accurately predict the most 
common DBS side effects (sustained paresthesias and dysarthria) in patients with 
well-positioned DBS leads.  
 
Methods: We utilized the VTA modeling methodologies presented in Chapter 3. 
VTAs of efficacious and side effect-inducing settings were calculated for N = 10 
ET patients who had undergone left thalamic DBS. We compared VTA overlap 
volumes with relevant anatomy (motor thalamus, sensory thalamus, internal 
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capsule) and correlated them to observed clinical effects (tremor control, sustained 
sensory paresthesias, dysarthria/speech side-effects). 
 
Results:  Individualized VTA predicts dysarthria resulting from internal capsule 
(IC) stimulation (Barnard’s Exact test, p < 0.05) whereas atlas-based VTA 
modeling does not (Barnard’s Exact test, p > 0.05).  There is no statistically 
significant difference in sensory thalamus stimulation between models during 
sustained sensory paresthesias (paired t-test, p > 0.05). The incidence of sustained 
sensory paresthesias on proximal contacts (2 and 3) indicates that paresthesias may 
result from stimulation outside of the sensory thalamus. 
 
Conclusions: Individualized VTA modeling may confer some advantages over 
traditional atlas-based approaches. Our results present an opportunity for improved 
DBS planning. 
 
Abbreviations: DBS, deep brain stimulation; ET, Essential Tremor; VTA, 
Volume of Tissue Activated; Vim, Ventral Intermediate; Vc, Ventrocaudal; MRI, 
Magnetic Resonance Imaging; DTI, Diffusion Tensor Imaging; VLPd, Ventral 
Lateral Posterior-dorsal ; VLPv, Ventral Lateral Posterior-ventral; VPL, Ventral 
Posterior Lateral; VPM, Ventral Posterior Medial; IC, Internal Capsule. 
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4.1. Introduction 
 
Thalamic deep brain stimulation (DBS) effectively controls medically-refractory 
kinetic and postural tremor in Essential Tremor (ET) [1-5]. Despite its efficacy, the 
mechanism of DBS remains controversial [6-8].  Thalamic DBS is especially 
difficult to study due to the inability to visualize the functionally-distinct nuclei of 
the thalamus [5].  
 
Modeling the volume of tissue activated (VTA) in DBS has been used to 
investigate the impact of stimulation parameters on clinical outcome in Parkinson’s 
disease (PD) DBS [9-16], though these studies rely on common brain-spaces for 
modeling. In our accompanying study, we presented an individualized VTA model 
for ET DBS and a preliminary comparison to traditional atlas-based VTA 
modeling. Using the methods presented in Chapter 3, we investigated the ability of 
individualized and atlas-based VTA models to explain common side effects from 
DBS in ET patients with well-positioned leads. 
 
During stimulation programming, ET patients typically experience side effects. 
While some side effects are transient and dissipate quickly, those that do not often 
become intolerable for the patient. The most common side effects from ET DBS 
are sensory paresthesias, dysarthria, and motor contractions. Sensory paresthesias 
are sensations such as numbness, burning, or tingling of the skin [17] and are 
thought to result from stimulation of the ventralis caudalis (Vc, or ventral 
posterior, VP) nucleus of the thalamus or the lemniscal fibers [18].  Approximately 
10% of patients experience sustained paresthesias during programming [19], and it 
can be avoided by reducing stimulation voltage, moving the probe anterior, or 
using a higher contact on the DBS lead. Dysarthria affects 5-25% of patients [20-
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22] and is thought to be caused by stimulation of the internal capsule (IC) or 
corticobulbar fibers, lateral to the DBS target for ET [23, 24]. While some patients 
can tolerate mild dysarthria in exchange for tremor control, dysarthria can be 
avoided with proper positioning of the DBS lead [17]. Motor contractions can also 
result from stimulation of the IC [25].  
 
In this study, we utilize VTA modeling to investigate common side effects from 
thalamic DBS in 10 ET patients with well-positioned leads. We implemented the 
methodology presented in an accompanying study to measure the VTA overlaps 
with nuclei of interest to correlate stimulation settings to clinical outcome. We 
compare the ability of individualized and atlas-based VTA modeling systems to 
explain common side effects. This article presents our results and discusses 
limitations and the potential for individualized modeling to be used prospectively 
for surgical planning.  
 
4.2. Materials and methods 
 
Using the methods from Chapter 3, we sought to understand the most common side 
effects from thalamic DBS in ET patients with well-placed leads. Stimulation 
volumes were then calculated for clinically-efficacious and side effect-inducing 
stimulation settings and their overlaps with relevant anatomy were compared.   
 
4.2.1 Patient Selection and Clinical Data 
We retrospectively evaluated the VTAs of the same 10 ET patients who had 
successfully undergone unilateral left Vim (VLPv) DBS for advanced idiopathic 
ET (6 men, 4 women, age mean ± SD 66 ± 7 years, range 49-74 years) and whose 
leads were confirmed to be well-placed (see Chapter 3). We performed the study in 
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accordance with the policies of the Medical Institutional Review Board of the 
University of Michigan. 
 
For VTA modeling, stimulation settings were selected from each patient’s first 
stimulation programming session with a Neurologist (KLC) following the post-
operative CT scan, 6-8 weeks post-DBS surgery. We recorded DBS settings on 
each contact (0-3) that controlled tremor without producing side-effects and 
stimulation settings on the same contacts that caused an explicitly noted side 
effect(s) (i.e., sustained sensory paresthesias, dysarthria, or speech issues).  
 
4.2.2 Image Data Acquisition and Analysis and Thalamic Segmentation  
Detailed methodology for image acquisition and analysis and thalamic 
segmentation can be found in Chapter 3.  
 
4.2.3 VTA Analysis 
The VTA is an estimate of the region(s) of the brain that fires action potentials 
under a given set of stimulation parameters [15]. We generated the VTAs for 
clinically efficacious and side effect-inducing stimulation settings, characterized 
their overlaps with relevant anatomy, and compared the performance of atlas-based 
and individualized VTA models in predicting side effects (sustained sensory 
paresthesias and dysarthria).  
 
All simulations were performed on a custom-built computer with 8 processors and 
48 GB memory (DEH Microsystems LLC, Cleveland, OH, USA) using BioPSE 
(Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, 
UT).  
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4.2.3.1 VTA Generation 
For each patient, atlas-based and individualized VTAs were generated 
individualized. The individualized VTA model followed the methodology 
presented in Chapter 3.  
 
4.2.3.2 VTA Evaluation 
For each stimulation setting, the overlap volumes between the VTA and the motor 
thalamus (VLPv, VLPd, VLa) sensory thalamus (VPM and VPL), and the internal 
capsule (IC, lateral to the thalamus) were recorded with the individualized and 
atlas-based models.  Overall agreement in VTA volumes between the two models 
was assessed with a two-tailed paired t-test. Within models, VTAs at side-effect 
threshold voltages were compared to VTAs at voltages eliciting tremor control 
with paired t-tests to assess the overlap between VTAs and nuclei thought to cause 
side effects (i.e., sensory thalamus or IC). Between models, the ability of 
individualized or atlas-based models to predict the incidence of side-effects was 
assessed by comparing VTA volume overlaps in the sensory nucleus and internal 
capsule with paired t-tests. The ability of VTA modeling to predict dysarthria and 
other speech side effects was measured with Barnard’s Exact test for each type of 
modeling (i.e., stimulation in the IC was treated as a binary variable). Barnard’s 
Exact test is more appropriate than a Chi-Squared test or Fisher’s Exact test 
because Fisher’s Exact test requires two fixed margins (not applicable here) and 
the Chi-Squared test is less powerful when any of the cell values in a 2x2 table are 
less than 5 [26, 27]. 
 
4.2.4 Statistical Methods 
Statistical analysis was performed using commercially available software: Excel 
(Microsoft Inc., Redmond, WA) and MATLAB (Mathworks, Natick, MA). For all 
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comparisons, statistical significance is defined at the p = .05 level. Sources of 
statistical variability in our data include quantization effects due to voxel 
representation intrinsic to MR imaging, motion artifacts in MR and CT imaging, 
and human error in measurement [28]. Data are displayed as mean ± SD except 
where otherwise noted. 
 
4.3. Results 
 
4.3.1 Clinical Outcome 
All 10 patients had improved tremor following successful DBS surgery without 
sustained paresthesias or dysarthria.  
 
4.3.2 VTA Analysis 
During stimulation setting adjustment, patients typically experience transient 
paresthesias that dissipate quickly [17].   However, in some stimulation settings, 
the paresthesias become sustained and may be intolerable for the patient [3]. 
Sensory paresthesias are a common side-effect of thalamic VLPv (Vim) 
stimulation and are thought to be the result of stimulation in the VPL (Vc) [29]. 
Other common side-effects include dysarthria and tonic contractions, both thought 
to be caused by IC stimulation [17].   
 
Paired t-tests show that there is no statistically significant difference between the 
sizes of VTAs generated by individualized and atlas-based modeling. The mean 
percentage difference between the size of individualized and atlas-based VTAs is 
0.26% ± 22.37%.  
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Figure 4-1 shows four stimulation settings in one patient with individualized 
VTAs. The top row shows the difference between tremor control (Fig. 4-1A, 0.7 
mm
3
 stimulation) and sensory paresthesias (Fig. 4-1B, 5.11 mm
3
) on the same 
contact. The bottom row shows another example of tremor control (contact 2) and 
sustained sensory paresthesias (contact 0), where contact 2 lies entirely within the 
VLPv and contact 0 is solidly within the sensory thalamus. Figure 4-2 shows an 
example of atlas-based and individualized VTA modeling predicting a VTA within 
the sensory thalamus, eliciting sensory paresthesias on contact 0. VTA models of 
two patients with dysarthria are shown in Figure 4-3. Atlas-based modeling (Figs. 
4-3A and 4-3C) predicts no IC stimulation, while fully individualized modeling 
(Figs. 4-3B and 4-3D) predicts IC stimulation, shown in blue. 
 
4.3.2.1 Within-Models Analysis 
Results of within-methods analysis is provided in Table 4-1. Both methods predict 
significantly more sensory thalamus stimulation in VTAs eliciting sustained 
sensory paresthesias than in cases without side effects. The methods differ on 
whether there is more IC stimulation in VTAs eliciting dysarthria than in cases 
without side effects.  
 
When stimulation is instead treated as a binary variable, individualized VTA 
modeling shows a statistically significant relationship between the presence of IC 
stimulation and dysarthria and other speech-related side effects (Barnard’s Exact 
test, p < 0.05), whereas atlas-based VTA modeling does not (Barnard’s Exact test, 
p > 0.05). Conversely, only atlas-based VTA modeling shows a statistically 
significant relationship between the presence of sensory thalamus stimulation and 
sustained sensory paresthesias (Barnard’s Exact test, p < 0.05; individualized 
Barnard’s Exact test, p > 0.05). 
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 Individualized Atlas-Based 
Sensory Thalamus stimulation with paresthesias: paired t-test (per contact) ** ** 
Sensory Thalamus stimulation with paresthesias: two-sample t-test   
IC stimulation with dysarthria: paired t-test (per contact) *  
IC stimulation with dysarthria: two-sample t-test   
Table 4-1. Summary of within-models statistical analysis.  Key: p < 0.01 = **; p < 0.05 = *; 
blank indicates lack of statistical significance (p > 0.05). 
 
4.3.2.2 Between-Models Analysis 
There is no statistically significant difference in the volume of sensory thalamus 
stimulation during sustained side effects (two-tailed paired t-test, p > 0.05). There 
is significantly more IC stimulation during dysarthria in individualized modeling 
(~12.7 mm
3
 vs. 0.44 mm
3
; one-tailed paired t-test, p < 0.05) 
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Figure 4-1. Comparison of Individualized VTAs on different contacts for the same patient.  
VTAs on different contacts induce different results in the same patient. (A) Tremor control on 
contact 1 (1.5 V). The VTA lies mostly within the motor thalamus, but there is small (0.7 mm
3
) 
stimulation in the sensory thalamus. (B) Sustained sensory paresthesias on contact 1 (2.5 V). The 
VTA extends further into the sensory thalamus (5.11 mm
3
). (C) Excellent tremor control on 
contact 2 (1.5 V). The VTA does not extend into the sensory thalamus. (D) On contact 0 (2 V), 
sustained paresthesias from sensory thalamus stimulation (18.25 mm
3
). Scale bars represent 10 
mm. (key: crimson = VLa, magenta = VLPd, pink = VLPv, purple = VPL, brown = VPM) 
  
A B 
C D 
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Figure 4-2. Comparison of Atlas-based and Individualized VTA modeling during sustained 
sensory paresthesias.  Atlas-based (left) and individualized (right) VTA models both predict 
sensory thalamus stimulation in a patient experiencing sustained paresthesias on contact 0 (1 V). 
Scale bars represent 10 mm. (key: crimson = VLa, magenta = VLPd, pink = VLPv, purple = 
VPL, brown = VPM) 
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Figure 4-3. Comparison of Atlas-based and Individualized VTA modeling during dysarthria.  (A) 
Atlas-based modeling shows a VTA that elicited dysarthria (Contact 3, 2.5 V) that lies entirely 
within the motor thalamus, with no stimulation in the IC. (B) Individualized modeling shows the 
VTA of the same setting with stimulation in the IC (indicated in blue, 2.09 mm
3
). (C) Atlas-
based modeling shows a VTA that elicited dysarthria (Contact 2, 2.5V) that lies mostly within 
the motor thalamus, with no stimulation in the IC. (D) Individualized modeling shows the VTA 
of the same setting with stimulation in the IC (indicated in blue, 33.43 mm
3
). Scale bars 
represent 10 mm. (key: crimson = VLa, magenta = VLPd, pink = VLPv, purple = VPL, brown = 
VPM) 
 
 
  
A B 
C D 
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4.4. Discussion 
 
In this study, we utilized an individualized VTA model to investigate side effects 
from thalamic DBS for ET. We conducted this investigation in two parallel tracks 
to compare the performance of atlas-based and individualized VTA modeling by 
assessing each model’s ability to correlate VTA location with patient outcomes 
across 10 ET DBS patients.  
 
4.4.1 Previous Work 
Prior computational investigations of ET DBS assumed that the division between 
the motor and sensory nuclei modulates the incidence of sensory paresthesias.  
However, no prior study implemented an individualized approach, instead co-
registering patient data to brain atlases or utilizing common brain spaces to draw 
conclusions across patients. The earliest of these studies estimated the spatial 
extent of activation in thalamic DBS with a basic amplitude-distance relationship, 
concluding that placing the DBS electrode in the posterior portion of the 
VLPv/Vim can cause stimulation of the VPL/Vc, and therefore sensory 
paresthesias, even at low voltages [30]. Pouratian et al. [31] analyzed the 
connectivity between the most efficacious DBS contact for tremor control and 
prefrontal, premotor, and primary motor cortical target masks using probabilistic 
diffusion tractography [32] within Montreal Neurological Institute (MNI) brain 
space.  It was determined that the most efficacious DBS contact for tremor control 
typically lies in an area with high likelihood of connectivity with the premotor and 
supplementary motor cortices. A recent study investigated the potential for 
directional DBS leads to modulate neuronal pathways with a finite-element electric 
field model of rodent Vc/Vim afferent and efferent neurons, though this study took 
a more simplified approach by assuming an isotropic homogeneous tissue 
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conductivity and utilized atlas nuclei warping instead of segmenting individually 
[29].  
 
4.4.2 VTA Analysis  
While there is no statistically significant difference in VTA sizes between models 
(paired t-test, p > 0.05), the standard deviation in percentage difference between 
models is large (~22%), indicating high variability. This finding may be explained 
by electrode positioning and surrounding tissue conductivity. The differences in 
electrode placement are attributable to the non-linear warping algorithm employed 
by Cicerone [33], which places each patient’s DBS lead in an appropriate position 
within the atlas thalamus [34]. Cicerone’s positioning of the DBS lead in the atlas 
thalamus may result in the active contact being placed in an area with different 
tissue conductivity compared to individualized modeling. Therefore, VTA sizes 
may vary between models.   
 
Our results suggest that there are differences in the predictive abilities of 
individualized and atlas-based VTA modeling. Individualized modeling can predict 
IC stimulation that results in dysarthria, while atlas-based modeling does not.  
Atlas-based modeling attributes the incidence of sustained sensory paresthesias to 
sensory thalamus stimulation, but individualized modeling suggests that the 
internal capsule may be responsible for paresthesias, especially those observed on 
proximal contacts (2 and 3).   
 
 
4.2.1 Dysarthria 
There are two major advantages to investigating dysarthria. First, dysarthria is an 
observable condition, unlike sustained sensory paresthesias. Second, dysarthria 
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results from IC stimulation, which is not dependent upon the accuracy of thalamic 
segmentation. However, IC stimulation is generally rare in atlas-based modeling. 
Cicerone’s electrode placement is generally too medial for a VTA to stimulate the 
IC compared to individualized modeling. Ultimately, individualized modeling 
places the electrode where it really is in the patient, which is often close to the 
lateral border of the thalamus. Individualized modeling is superior to atlas-based 
modeling in both within- and between-models analyses in the ability to predict 
dysarthria from IC stimulation.  
 
4.2.2 Sustained Sensory Paresthesias 
As expected, sensory thalamus stimulation is relatively uncommon in patients with 
well-placed leads. Nevertheless, most patients experienced sustained sensory 
paresthesias on proximal contacts (2 and 3), which are anterodorsal to the sensory 
thalamus in well-positioned leads, regardless of thalamic segmentation results. Of 
the 23 settings that caused sustained sensory paresthesias, 8 occurred on contact 0, 
7 on contact 1, 5 on contact 2, and 3 on contact 3; therefore, nearly a third of 
sustained sensory paresthesias in this study cannot be attributed to sensory 
thalamus stimulation. An analysis between models reveals no significant difference 
in the volume of sensory thalamus stimulated, suggesting good agreement between 
models, and in both models, there is more sensory thalamus stimulation at 
paresthesia thresholds in a paired analysis on each contact. However, sensory 
thalamus stimulation is not greater overall when comparing tremor control to 
sensory paresthesias. This result suggests three things: (1) that some sensory 
thalamus stimulation does not necessarily elicit sustained paresthesias, (2) that the 
k-means algorithm is not correctly predicting the boundaries of the thalamic nuclei 
and (3) that sensory paresthesias may result from stimulation outside of the sensory 
thalamus. Lastly, sustained paresthesias are not an observable side effect, unlike 
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dysarthria. Given that DBS programming does not occur in a randomized order, 
there is reason to believe that patients may over-report the incidence of sustained 
sensory paresthesias or mistake a mild motor contraction for a sensory paresthesia. 
We considered the possibility that IC stimulation causes some paresthesias. In 
individualized modeling, 76% of paresthesias not attributable to sensory thalamus 
stimulation may result from IC stimulation (compared to atlas-based modeling, 
30%). Assuming this alternative explanation for patient-reported sensory 
paresthesias, individualized modeling predicts 87% of sensory paresthesias while 
atlas-based modeling only predicts 70%. 
 
4.4.3 Limitations and Future Directions 
The interpretation of our results is subject to several limitations. First, our sample 
size (N = 10) is relatively small; we restricted this investigation to include only 
patients without co-morbid conditions and with well-placed leads. Though our 
sample size is larger than most other VTA studies, it is still likely insufficient for 
robust statistical analysis.  Additionally, DTI is low-resolution, and VTA analysis 
and thalamic segmentation rely on resampling the DTI images; there is expected 
error from DTI resampling, especially at tissue boundaries. Next, this study was 
restricted to monopolar stimulation settings at a frequency of 130Hz and pw of 60 
µs; different frequencies and pulse widths are subject to different axonal activation 
functions within the VTA model. The neurologist’s (KLC) DBS programming 
protocol is standardized but not randomized, which may result in false positive side 
effect reporting. Our analysis of sustained sensory paresthesias is limited by the 
thalamic segmentation method used. Though more robust methods have been 
reported in the literature [35], the k-means algorithm was a convenient choice for 
the retrospective data available. While the analysis of IC stimulation is not limited 
by thalamic segmentation, it remains limited by the accuracy of parcellation. 
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Further, VTA analysis is complicated by the fact that characterizing stimulation 
overlap is inherently difficult. Even if thalamic segmentation were completely 
correct, the exact locations within certain nuclei that can produce side effects or 
tremor control when stimulated are not known. As a result, whether to treat VTA 
overlap as a volume measurement or a binary variable for analysis is unclear. 
While atlas-based modeling theoretically has the advantage of determining 
common locations for tremor control or side effects, our data suggests that the 
shortcomings of atlas-based modeling may preclude such an investigation.  
 
We plan to implement individualized modeling in a prospective analysis of ET 
patients undergoing DBS. Given the demonstrated ability of individualized 
modeling to correlate IC stimulation with dysarthria, we will evaluate this 
technique’s ability to prospectively predict side-effects based on electrode 
placement and VTA stimulation overlaps. 
 
4.5. Conclusions 
A comparison of individualized VTA modeling to existing atlas-based VTA 
modeling suggests that individualized VTA modeling better explains the incidence 
of side effects, especially dysarthria from IC stimulation.  A prospective study is 
planned for further investigation (see Chapter 5).  
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  Chapter 5
 
Conclusions and Future Directions 
 
5.1 Conclusions 
 
Optimized targeting is of considerable interest to neurosurgeons and researchers 
aiming to improve the safety and efficacy of DBS surgery. The work presented in 
this dissertation advances the knowledge of proper DBS surgery targeting for 
movement disorders. The results in Chapter 2 resolve a longstanding debate in the 
DBS field by establishing a superior indirect targeting technique for STN DBS 
with a validated imaging protocol. Neurosurgeons relying on indirect targeting for 
STN DBS should routinely use the RN-based technique over the MCP-based 
technique due to its greater accuracy and precision. Chapter 3 presents an 
individualized targeting and tissue activation modeling system for thalamic Vim 
DBS. The k-means clustering algorithm presented in Chapter 3 is robust and 
capable of accurately segmenting the thalamus into its functionally-distinct nuclei. 
Because preliminary results in Chapter 3 indicate that individualized VTA 
modeling may be superior to atlas-based modeling, Chapter 4 compares the 
performance of individualized and atlas-based VTA modeling by applying them to 
the study of common side effects of thalamic DBS. Results demonstrate that 
individualized VTA modeling is superior to atlas-based modeling in the ability to 
predict certain side effects. The individualized VTA model for thalamic VLPv 
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(Vim) DBS is currently the most patient-customized DBS model available and is 
adaptable to other DBS targets. The development of individualized DBS targeting 
and modeling is a substantial step towards optimized DBS targeting, but additional 
work is required to further validate the model and test it in a prospective setting. 
 
5.2 Future Directions 
 
5.2.1 Current Techniques 
Atlas-based modeling has the theoretical advantage of allowing for easy 
comparison across subjects. By modeling VTAs in a single brain, researchers may 
find specific targets (e.g., dorsal STN for PD tremor [1-5]) that produce common 
clinical effects across patients. This can be accomplished by calculating the 
intersection of VTAs across a cohort experiencing the same clinical effect. 
However, Chapters 3 and 4 demonstrated that atlas-based VTA modeling may 
position the probe in an inappropriate location, which would preclude an accurate 
analysis of common clinical targets. A shift towards individualized modeling is 
justified according to the results presented in this dissertation, and could assist in 
proper DBS targeting for movement disorders.  
 
5.2.2 Changes Required for Implementation of Proposed Methods  
Implementation of thalamic segmentation-based DBS targeting would ideally 
involve rigorous validation beyond the results presented in Chapter 3. As discussed 
in Chapter 3, there is no in-vivo gold standard for validating the results of the 
segmentation algorithm. There are two options for validation. The first is to 
superimpose the results of thalamic segmentation onto patient-specific fiber 
tractography and probabilistic connectivity maps with the methodology presented 
by Pouratian et al. [6]. A significant drawback to this proposal is that fiber 
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tractography and probabilistic connectivity rely on DTI, and therefore suffer from 
the same limitations as our segmentation algorithm. Improved DTI resolution may 
overcome this drawback. Alternatively, a long-term validation study could be 
attempted with post-mortem data. By conducting histological staining as presented 
by Morel et al. [7] to compare the results of thalamic segmentation with 
histological boundaries, the segmentation algorithm could potentially be validated. 
The major drawbacks to this proposal are the significant time investment and 
potentially small sample size. 
 
Further, implementation of thalamic segmentation-based DBS targeting would 
require several changes to existing technology (StealthStation Surgical Navigation 
System, Medtronic, Minneapolis, MN). The StealthStation system currently orients 
an anatomic MR image along the intercommissural and interhemispheric planes 
with user guidance. An anatomic atlas (Schaltenbrand and Wahren [8]) is overlaid 
onto the image, and the neurosurgeon manually positions and scales the atlas to 
match the MR image. Once the neurosurgeon feels that the atlas is properly scaled, 
the StealthStation provides target coordinates, taking into account the length of the 
AC-PC line. This method is limited by its simplicity and is prone to error. Unlike 
commercial image coregistration programs (e.g. Analyze 11.0, AnalyzeDirect, 
Overland Park, KS) with automated coregistration algorithms [9], current 
stereotactic targeting relies on a neurosurgeon to properly scale an atlas. However, 
without the assistance of a built-in coregistration algorithm, this procedure is 
imprecise and potentially inaccurate.  
 
In order to implement thalamic segmentation, three additional data sets would be 
necessary: the coordinates of the thalamus (manually parcellated prior to surgery, 
which takes approximately 30 minutes for an experienced user), corresponding 
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diffusion tensors for each voxel in the thalamus, and the centroids of the atlas 
thalamic nuclei. The coordinates of the thalamus can be exported by Analyze 11.0, 
and corresponding diffusion tensors can be exported by Matlab (Mathworks, 
Natick, MA). A more powerful system would require the processing power to 
automatically calculate diffusion tensors from DTI images and crop thalamic 
tensors from the loaded parcellated thalamus. The coordinates of atlas thalamic 
nuclei centroids would need to be calculated only once, and stored as a feature of 
the StealthStation. Initial centroid coordinates of thalamic nuclei could be derived 
from the coordinates reported by Deoni et al. [10], but would require a coordinate 
transformation to scale them appropriately for each patient. Neurosurgeons would 
continue to manually scale the atlas to match the patient brain for two reasons. 
First, atlas scaling would give the standard targeting coordinates for a prospective 
study. Second, the transformation matrix from atlas scaling could be used to 
calculate appropriate initial centroids for the k-means thalamic segmentation 
algorithm via a rigid coordinate transformation.  
 
Once the initial centroid coordinates are transformed into patient space, the 
algorithm would take less than 10 minutes to run (provided the specifications of 
the intraoperative machine are similar to the computers described in Chapters 3 
and 4). The algorithm is capable of outputting the coordinates of the centroid of 
any nucleus and all the voxel coordinates that lie within a nucleus. The Y and Z 
coordinates of the VLPv centroid could be used for initial DBS targeting; the X 
coordinate of the VLPv centroid is generally not used for DBS targeting due to the 
somatotopic organization of the thalamus [11]. The active contact is situated 
approximately 1.8 medial to the VLPv centroid, according to our data.  Contact 2 
on the 3387 Medtronic probe would most likely be used for targeting the location 
recommended by the segmentation algorithm.  
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The coordinates of the DBS target could be refined with VTA-based targeting and 
parameter selection. Implementation of VTA-based stimulation parameter 
selection would be more complicated, and would require more computationally 
powerful equipment than what is currently used. Further, an intraoperative VTA 
model would require that there be no fibrous capsule assumption. Generally, good 
tremor control is found at stimulation voltages less than 3V where the VTA lies 
entirely within the motor thalamus (preferably VLPv, though sometimes VLPd and 
VLa). Overlap with the sensory thalamus (VPL, VPM) must be avoided as well as 
overlap with the IC, which was demonstrated in Chapter 4 to reliably indicate the 
presence of dysarthria. 
 
5.2.3 Benefits and Trade-Offs of Proposed Methods 
The major trade-off with more complex targeting and modeling for DBS surgical 
planning is time. The current system is straightforward to operate and does not 
require a significant time investment; neurosurgeons are able to determine a target 
in a matter of minutes. Considering the high percentage of successful surgeries, the 
current system works well enough for clinical benefit. However, improved 
targeting has two main benefits: 1) fewer surgical tracks and 2) lower voltage to 
stimulate the correct spot, extending battery life and minimizing the incidence of 
side effects. Specifically, given that some patients tolerate some dysarthria in 
exchange for tremor control [12], there is clinical interest in being able to properly 
target to avoid dysarthria. Modeling and targeting could take place weeks before 
surgery, or as soon as pre-operative MR and DT imaging is completed. 
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5.2.4 Prospective Study  
We plan to conduct a prospective consecutive study on ET patients in two parts 
order to directly test the conclusions of this dissertation: thalamic segmentation-
based targeting and preoperative side-effect prediction. ET Patients will be 
evaluated per DBS Pathway guidelines at the University of Michigan, and 
comorbid conditions will be noted. 10 ET patients with limited or no comorbid 
conditions will be selected to participate in this study. We will obtain institutional 
review board approval from the University of Michigan prior to selecting patients.  
 
First, the viability of thalamic segmentation for DBS targeting will be tested. 
Thalamic segmentation will be performed preoperatively and targeting will be 
informed by the position of the centroid of the VLPv nucleus.  The Y and Z 
coordinates of the VLPv centroid will be the DBS target for contact 2 of the 3387 
probe, while the X contact will be 1.8 mm medial to the X coordinate of the VLPv 
centroid. This trajectory will be compared to the standard thalamic DBS targeting 
protocol (see Chapter 1 for details; the distal tip of the electrode is placed 
according to atlas relationships, and contact 1 is the most common final active 
contact). The neurosurgeon will attempt two surgical trajectories in a randomized 
order with the standard and segmentation-based target coordinates. Tremor 
control—measured quantitatively with an accelerometer—will be compared for the 
two trajectories. The trajectory that reduces tremor the most (without any side 
simultaneous side effects) will be considered superior. If both trajectories 
effectively control tremor, the trajectory without side effects at the lowest voltage 
will be deemed the superior trajectory. It would be unsafe to proceed with each 
trajectory as though it were being independently evaluated (i.e., with multiple 
passes around the initial trajectory) due to the increased risk of intracranial 
hemorrhage [13]. As discussed in Chapter 2, simply calculating the distance 
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between a target coordinate and the final active contact as a way to determine 
optimal targeting is improper, as the position of the final active contact is 
ultimately determined by whichever targeting protocol is used.  
 
Therefore, for the second part of the study, VTA overlaps with relevant nuclei (i.e., 
motor thalamus, sensory thalamus, IC) will be measured preoperatively for the 
target coordinates. For standard thalamic DBS targeting and segmentation-based 
thalamic DBS targeting, contacts 1 and 2 would be used, respectively. The VTAs 
will be generated for each targeting method for a monopolar stimulation 
configuration (frequency 130 Hz, pulse width 60 µs) at a range of voltages (0.5-5 
V at 0.5 V increments). The incidence of sustained sensory paresthesias and 
dysarthria will be predicted prior to surgery with the intraoperative individualized 
VTA model, and intraoperative side-effects will be noted and compared against 
those predictions during randomized stimulation parameter testing.  
 
This intraoperative prospective study would help to overcome the limitations of the 
retrospective data used in Chapters 3 and 4. However, an inherent difficulty of this 
study is the lack of statistical power; sample size is likely to remain low (N < 10). 
With improvements in imaging protocols, thalamic segmentation and VTA 
modeling will become refined. Ultimately, the goal is to understand how VTA 
modeling can predict good tremor control and avoid side effects, and further work 
will involve correlating VTA size and position to tremor frequency.  
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